EP1002101A2 - Proteines antigel, adn et systemes d'expression - Google Patents

Proteines antigel, adn et systemes d'expression

Info

Publication number
EP1002101A2
EP1002101A2 EP98937376A EP98937376A EP1002101A2 EP 1002101 A2 EP1002101 A2 EP 1002101A2 EP 98937376 A EP98937376 A EP 98937376A EP 98937376 A EP98937376 A EP 98937376A EP 1002101 A2 EP1002101 A2 EP 1002101A2
Authority
EP
European Patent Office
Prior art keywords
antifreeze
proteins
plants
polypeptide
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98937376A
Other languages
German (de)
English (en)
Inventor
Choy Hew
Fei Xiong
Barbara Moffatt
Marilyn Griffith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ice Biotech Inc
Original Assignee
Ice Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ice Biotech Inc filed Critical Ice Biotech Inc
Publication of EP1002101A2 publication Critical patent/EP1002101A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8273—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for drought, cold, salt resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2442—Chitinase (3.2.1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01014—Chitinase (3.2.1.14)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants

Definitions

  • the invention relates to plant antifreeze proteins, peptides and polypeptides (also referred to as "AFPs") that bind to ice crystals and inhibit their growth, inhibit ice recrystallization and protect liposomes, cell membranes and proteins, cells and organisms at low temperatures.
  • AFPs plant antifreeze proteins, peptides and polypeptides
  • the invention also relates to DNA sequences that encode proteins with both chitinase and antifreeze activities and the expression of these DNA sequences in bacteria, yeast, plants and animals for the production of chitinases with antifreeze activity.
  • Low temperature is a major environmental limitation to the production of agricultural crops. For example, late spring frosts delay seed germination, early fall frosts decrease the quality and yield of harvests and low winter temperatures decrease the survival of overwintering crops, such as winter cereals and fruit trees. However, some plants have the ability to withstand prolonged subfreezing temperatures. With the identification and isolation of proteins involved in the development of freezing tolerance in these plants, as well as the corresponding genes, freezing-sensitive crop plants can be transformed into freezing-tolerant crop plants and extend the range of crop production.
  • Guy et al. (1-5.1) analyzed the total protein content of cold-acclimated spinach tissues compared with tissues from warm-grown plants to find proteins associated with freezing tolerance. Proteins found in cold-acclimated leaf extracts with molecular masses of 110, 82, 66, 55 and 13 kD were not found in warm-grown leaf extracts. Guy et al. (1-5.2) also examined the total protein content of cold-acclimated spinach leaves and observed the accumulation of high molecular mass proteins (110, 90 and 79 kD). As with Guy et al. (1-5.1), the location and function of these proteins within the plant remain unknown. It was known, however, that many biological organisms survive subzero environments by avoiding ice formation.
  • AFPs antifreeze proteins
  • THPs thermal hysteresis proteins
  • AFPs Four distinct types were identified in fish (II-4) and a number of different THPs were identified in insects (111-12). These previous findings suggest that this adaptive mechanism has arisen independently in different organisms and that this mechanism is responsible for preventing any ice formation within the organism. It was generally understood that AFPs did not exist in plants because most plants that survive prolonged exposure to subzero temperatures actually form ice in their tissues, usually in intercellular spaces and xylem vessels. Kurkela and Franck (1-9.1) reported that a plant gene expressed at low temperature encodes a protein similar in amino acid sequence to the flounder AFP of Davis and Hew (II— 4). Kurkela and Franck (1-9.1) did not have sufficient amounts of the encoded protein to determine whether it exhibited antifreeze activity.
  • a CAT-AFP fusion protein was produced, but it was not secreted efficiently and no antifreeze activity was detected.
  • AFPs isolated from fish and insects have been used in developing new additives for food products and biological materials stored at low and subzero temperatures and in transforming plants, these proteins have not entered the marketplace because they are perceived by consumers to be inappropriate. For example, the addition of a fish AFP to ice cream is not acceptable whereas the addition of a plant AFP to ice cream is acceptable to consumers.
  • the use of AFPs isolated from plants is expected to be more widely applicable in the marketplace than AFPs already characterized from animals.
  • Figure 1 depicts concentrations of extracellular proteins from winter rye leaves grown under various temperature regimes.
  • Figure 2 depicts SDS-PAGE of extracellular polypeptides isolated from winter rye leaves grown under various temperature regimes.
  • Lane 1 molecular mass markers
  • lane 2 extracellular polypeptides from rye plants grown at 20/16° C (day/night) with a 16-hour day
  • lane 3 extracellular polypeptides from rye plants grown at 5/2° C with a 16-hour day
  • lane 4 extracellular polypeptides from rye plants grown at 5/2 °C with an 8-hour day.
  • Figure 3 depicts SDS-PAGE of extracellular polypeptides isolated from cold- acclimated winter rye leaves grown with an 8-hour daylength at different stages of development.
  • Lane 1 molecular mass markers; lane 2, extracellular polypeptides from rye plants grown at 20/16° C with a 16-hour day for 7 days; lane 3, extracellular polypeptides from rye plants (20/16 °C, 7 days old) transferred to 5/2° C with an 8- hour day for 28 days; lane 4, extracellular polypeptides from rye plants transferred to 5/2 °C for 43 days; lane 5, extracellular polypeptides from rye plants transferred to 5/2° C for 50 days; lane 6, extracellular polypeptides from rye plants transferred to 5/2 °C for 71 days; lane 7, extracellular polypeptides from rye plants transferred to 5/2 °C for 95 days.
  • Figure 4 depicts SDS-PAGE of extracellular polypeptides isolated from deacclimated winter rye leaves.
  • Lane 1 molecular mass markers
  • lane 2 extracellular polypeptides from plants grown at 20/16° C for 7 days and then transferred to 5/2° C with an 8-hour day for 42 days
  • lanes 3, 4 and 5 extracellular polypeptides from plants grown as described in lane 2 and then transferred to 20/16° C with an 16-hour day for 4, 6 and 8 days, respectively.
  • Figure 5 depicts the ice nucleation activity of various ultrafiltered extracellular extracts from rye leaves grown under different temperature regimes.
  • Figure 6 illustrates the antifreeze activity in extracellular extracts of cold- acclimated winter rye leaves. Antifreeze activity was determined by observing ice crystal morphology using a nanoliter osmometer (Clifton Technical Physics, Hartford, N.Y., U.S.A., 11-5). Orientation of the ice crystals in C, D, E and F: the a-axis represents growth in the basal plane and the c-axis represents growth normal to the basal plane.
  • Figure 7 illustrates fractionation of extracellular extracts from cold-acclimated rye leaves by column chromatography.
  • Figure 8 illustrates the ice crystal morphology of partially purified and concentrated antifreeze protein from cold-acclimated winter rye leaves.
  • A Orientation of the crystal as described in Fig. 6.
  • B, C and D Growth sequence of an ice crystal as the temperature was lowered.
  • Figure 9 is SDS-PAGE of polypeptides associated with column fractions of each 280 nm peak shown in Fig. 8.
  • Figure 10 depicts extracellular polypeptides from cold-acclimated winter rye leaves separated by SDS-PAGE using Tris-tricine buffers. The polypeptides were eluted from the gel and assayed for activity. The 161 , 93 to 99, 33, 31 , 27,23, 15 and 11 kD polypeptides all exhibited antifreeze activity.
  • Figure 11 depicts extracellular extracts from A: nonacclimated and B: cold-acclimated winter rye leaves. Polypeptides were solubilized and separated by SDS-PAGE and then probed with anti-chitinase antiserum as the primary antibody. Molecular mass standards (in kD) are shown in lane C.
  • Figure 12 shows an immunoblot of extracellular extract from cold-acclimated winter rye leaves. Polypeptides were separated by SDS-PAGE, blotted onto nitrocellulose and probed with anti-chitinase antiserum as the primary antibody.
  • Figure 13 depicts recrystallization inhibition in extracellular extracts obtained from cold-acclimated winter rye plants. At the 1 :10,000 dilution, the protein concentration was approximately 28 ug/L. Splats were formed at -20° C and were annealed at -8°C for 6 hours. (NOTE: Splats were annealed at -8° C for 6 hours to observe recrystallization of ice. Photographed by Dr. Charles Knight, National Center for Atmospheric Research, Boulder, CO, USA.)
  • Figure 14 depicts the level of freezing injury, measured as ion leakage, in nonacclimated leaves ( ⁇ ), cold-acclimated leaves ( ⁇ ) and cold-acclimated leaves which were extracted before freezing to decrease the levels of extracellular proteins (v).
  • Figure 15 shows antifreeze activity in leaves of nonacclimated (NA) and cold- acclimated (CA) plants. Antifreeze activity was determined for each leaf extracellular extract by observing the morphology of ice crystals grown in solution. No antifreeze activity was observed in all nonacclimated leaf extracts. Extracts of cold-acclimated kale and winter canola leaves, as well as cold-acclimated winter and spring rye, winter and spring wheat, winter barley and spring oats leaves all exhibited antifreeze activity. All crystals were photographed at the same magnification. The magnification bar represents 17 ⁇ m.
  • Figure 17 Accumulation of extracellular polypeptides and immunodetection of antifreeze proteins in winter rye cv Voima.
  • NA nonacclimated
  • CA rye cold-acclimated
  • CLP chitinase-like protein
  • GLP glucanase-like protein
  • TLP thaumatin-like protein
  • Figure 18 depicts the accumulation of extracellular polypeptides in nonacclimated (NA) and fully cold-acclimated (CA) cereals. Equal amounts (1 ⁇ g per lane) of concentrated extracellular polypeptides were separated in 15% SDS-poiyacrylamide gels.
  • A A gel stained with Bio-Rad silver stain. The gels were blotted and probed with B: anti-GLP antiserum (dilution 1 :10 000), C: anti-CLP antiserum (dilution 1 :1000), and D: anti-TLP antiserum (dilution 1 :10 000). Numbers on the left refer to the Bio-Rad low molecular mass markers.
  • Figure 19 depicts the accumulation of extracellular polypeptides in nonacclimated (NA) and fully cold-acclimated (CA) dicotyledons. Equal amounts (1 ⁇ g per lane) of concentrated extracellular polypeptides were separated in 15% SDS-polyacrylamide gels. A: A gel stained with Bio-Rad silver stain. After transfer, immunoblots were probed with B: anti-GLP antiserum (dilution 1 :10 000), C: anti-CLP antiserum
  • Figure 20 shows the total sugars present in extracellular extracts from nonacclimated (white bars) and cold-acclimated (hatched bars) monocotyledonous (A) and dicotyledonous (B) plants.
  • FIG. 21 depicts DNA and protein sequences for a chitinase-like protein with antifreeze activity, a: ch-9 full length DNA and amino acid sequence; b: ch-9 DNA and amino acid sequence (lacking the predicted signal peptide coding region); c: ch- 9 including a presequence of 20 amino acids that is removed in the plant cell (the final purified protein that has chitinase and antifreeze activity is lacking this presequence); d: ch-9 amino acid sequence lacking a presumptive signal sequence of 20 amino acids.
  • Figure 22 depicts DNA and protein sequences for a chitinase-like protein with antifreeze activity, a: ch-46 DNA and amino acid sequence (removed untranslated sequences and the putative presequence); b: ch-46 DNA and amino acid sequence (removed untranslated sequences); c: ch-46 (putative signal sequence removed; d: ch-46 (untranslated sequence removed).
  • Figure 23 is a multiple sequence alignment of amino acid sequences of chitinases from different plants.
  • 1 is the amino acid sequence of chitinase-a from rye seeds (Protein Information Resource Accession No. JC2071)
  • rye is chitinase-c from rye seeds
  • Protein Information Resource Accession No. JN0884, pCHT9 and pCHT46 are the predicted amino acid sequences for two winter rye chitinase-like proteins with antifreeze activity.
  • Figure 24 shows the expression of DNA sequences and secretion of chitinase-like protein in E.coli.
  • Total cell extract was prepared from uninduced (lanes 1 , 3) and IPTG-induced cells (lanes 2, 4), separated by SDS-PAGE and subjected to immunoblotting.
  • a 32 kD protein recognized by the anti-chitinase-like protein antiserum is evident in the induced cells (lanes 2, 4).
  • chitinase-like protein purified from cold-acclimated winter rye (M).
  • Figure 25a shows the expression and secretion of chitinase-like protein in yeast.
  • Yeast cells were grown in YPD medium for 24 hr (lane 1), 48 hr (lane 2). Cells were centrifuged, the supernatant was mixed with sample buffer, and the polypeptides were separated by SDS-PAGE. A 32 kD polypeptide is present in both lanes.
  • Figure 25b shows an immunoblot analysis of both supernatant and cell pellet with anti-chitinase-like protein antiserum. Proteins from both the supernatant (lanes 3, 4) and the cell pellet (lanes 1 , 2) were solubiiized, separated by SDS-PAGE and subjected to immunoblotting. The majority of proteins are found in the supernatant (lanes 3, 4). Also shown is chitinase-like protein purified from cold-acclimated winter rye.
  • Figure 26 shows heat-stable AFPs separated by SDS-PAGE. Extracellular extracts from cold-acclimated winter rye leaves were heated (lane A) to 60°C for 30 min or (lane B) to 100°C for 10 min. Lane C shows BioRad braod range molecular mass markers (207, 121 , 81, 51.2, 33.6, 28.6, 21.1 , and 7.5 kD). GLP: glucanase-like protein; TLP: thaumatin-like protein. SUMMARY OF THE INVENTION
  • extracellular polypeptides are located in the extractable portion of the plant apoplast, which includes the outer surface of the plasmaiemma, the region between the plasmaiemma and the cell wall, the cell wall, the middle lamella, the intercellular spaces and the tracheids and vessels of the xylem. It is understood throughout this specification that the term extracellular has the above meaning.
  • Winter rye is an overwintering herbaceous annual plant that survives temperatures lower than -20°C.
  • winter rye leaves freeze ice grows in intercellular spaces within the mesophyll and in xylem vessels (III— 40).
  • the survival of frozen plant tissues depends on preventing cellular damage caused by the growth of intercellular ice crystals.
  • AFPs that accumulate in the apoplast of winter rye leaves during cold acclimation have the ability to modify the growth of ice crystals in frozen tissues (111-19, III-22) and are correlated with greater freezing tolerance of the winter rye leaves (III-35).
  • the AFPs are associated with the epidermis and with mesophyll cells that surround intercellular spaces of cold-acclimated winter rye leaves (III-2). These locations correspond to the known sites of ice formation on the surface of the leaf and in intercellular spaces within the mesophyll (111— 40, 111-41) and suggest that AFPs may also prevent inoculative freezing of cells (111-41).
  • AFPs ranging in molecular mass from 16 to 35 kD have been isolated from the apoplast of cold-acclimated winter rye leaves (III-22). They are similar to members of three classes of pathogenesis-related (PR) proteins: two AFPs are chitinase-like proteins (CLPs), two are ⁇ -1 ,3-glucanase-like proteins (GLPs) and two are thaumatin-like proteins (TLPs, III-23).
  • CLPs chitinase-like proteins
  • GLPs ⁇ -1 ,3-glucanase-like proteins
  • TLPs thaumatin-like proteins
  • One CLP was purified to homogeneity from cold-acclimated winter rye leaves and shown to have both antifreeze and chitinase activities (111-23).
  • low temperature rye proteins exhibit two activties, they may play a role in nonspecific disease resistance (chitinase and glucanase activity) as well as in freezing tolerance (antifreeze activity, 111-48). If the ability to modify the growth of ice in the apoplast is an important component of freezing tolerance, then it is probably a widespread mechanism among plants. Surveys of overwintering plants have shown that there is antifreeze activity in the sap expressed from the tissues of many plants, including 21 dicotyledonous and 9 monocotyledonous plants (111-19, 111-17, III-52, 111-11 , 111-12).
  • AFP has also been isolated from the expressed sap of Solanum dulcamara, an overwintering woody vine known as bittersweet nightshade (111-10).
  • the nightshade AFP is a large (67 kD) glycosylated protein with an usually high glycine content (ca 24%) and a unique N-terminal amino acid sequence (111-10).
  • AFPs isolated from plant sources are important additives for processes that involve modifying ice formation, reducing disease, decay and spoilage caused by microorganisms at low temperature, and ameliorating the results of exposure to low temperatures, including the production and storage of frozen foods and cryopreservation of biological materials.
  • the genes encoding AFPs are important in expression systems for increased production of AFPs to use as additives and in transgenic organisms to increase AFP synthesis to promote survival and reduce injury and disease in cold environments.
  • AFPs common to freezing-tolerant plants are provided.
  • the proteins are located extracellularly to control ice crystal growth in the xylem and intercellular spaces within plant tissues. This modification of ice crystal growth contributes to the plants' ability to withstand freezing.
  • polypeptides with antifreeze activity are selected from a group of polypeptides having respectively apparent molecular masses of about 5 to 9 kD, about 9 to 11 kD, about 11 to 15 kD, about 21 to 23 kD, about 24 to 27 kD, about 30 to 31 kD, about 31 to 33 kD, about 32 to 36 kD, about 60 and 68 kD, about 89 to 100 kD and about 161 kD.
  • polypeptides having the above molecular masses and deriving from extracellular spaces of freezing-tolerant plants are provided.
  • Some of the polypeptides are ice nucleators that initiate ice in extracellular spaces of plant tissues.
  • Some of the polypeptides are AFPs that modify ice crystal growth in extracellular spaces.
  • Some of the polypeptides are enzymes that modify plant cell walls and/or inhibit the growth of pathogens in plant intercellular spaces.
  • the polypeptides have been characterized by their apparent molecular masses based on their migration in SDS-PAGE gels relative to known molecular mass markers. It is appreciated that the polypeptides of this invention may migrate differently in different types of gels, particularly with different concentrations of acryiamide in the gel, with different reducing conditions and with different running buffers. Hence, the molecular mass characterization of the polypeptides of this invention is intended to cover the equivalent polypeptides as they might have slightly different molecular masses on different gels. Moreover, the extracellular polypeptides are found in extracts containing total soluble proteins from the plant tissues. Hence, the invention is intended to cover these polypeptides whether they are extracted only from the extracellular spaces or from total extracts of the tissues.
  • AFPs from herbaceous monocotyledonous and dicotyledonous plants are provided. Antifreeze activity and total protein accumulation were found in leaf extracellular extracts from eight herbaceous plants grown at low temperature, including both monocotyledons (winter and spring rye, winter and spring wheat Triticum aestivum L., winter barley Hordeum vulgare L., spring oats Avena sativa L.) and dicotyledons (winter canola Brassica napus L. and kale Brassica oleracea L.).
  • the secretion of extracellular proteins capable of modifying ice crystal growth is one aspect of the mechanism for winter survival in both monocots and dicots.
  • the invention relates to an isolated polypeptide having antifreeze activity, selected from the group consisting of members of the Poaceae and Cruciferae families.
  • the member of the Poaceae is selected from the group consisting of barley, wheat and rye, spring rye, winter rye, spring wheat, winter wheat, winter barley and spring oats, whereas the member of the Cruciferae is selcted from kale and winter canola.
  • certain monocots upon cold induction or acclimation, produce a family of AFPs that are related to pathogenesis- related proteins as shown by N-terminal sequences of cold-induced proteins and immunoblots. It is provided that related plants from the family Poaceae, including rye, wheat, and barley, accumulate AFPs similar to pathogenesis-related proteins during cold acclimation. Therefore, the invention also relates to cold-induced pathogenesis-related proteins with antifreeze activity isolated from a monocot. The monocot is preferably from the Poaceae family.
  • the monocot is selected from the group consisting of barley, wheat and rye, spring rye, winter rye, spring wheat, winter wheat, and winter barley.
  • the invention also includes a mimetic of each polypeptide.
  • the polypeptide(s) of the invention may be selected from the group consisting of chitinase-like protein, thaumatin-like protein and glucanase-like protein.
  • the polypeptide(s) may be used for producing antifreeze protein, increasing freezing tolerance in plants and microorganisms, inhibition of ice recrystallization in biological matter or food product, reducing disease, decay or spoilage caused by microorganisms active at low temperature in biological matter or food product, cryopreservation of cells, hypothermic protection of cells, cold protection of human platelets and killing tumor cells.
  • antibodies to one or more of the aforementioned polypeptides may be developed, such antibodies being optionally adapted for detection in an immunoassay for determining the level of freezing tolerance or for determining if similar AFPs are produced by other plants.
  • frozen food preparations may include one or more of the above polypeptides and, in particular, ice cream and fruit preparations which include one or more of the polypeptides to provide a superior product having minute crystalline structure.
  • the polypeptides are useful in the cryopreservation of biological tissues, frozen storage of a variety of tissues and frozen germplasm storage.
  • the sugars present in the extracellular extracts of cold-acclimated plants also modify the growth of intercellular ice and inhibit ice recrystallization. These sugars enhance the activity of AFPs.
  • two chitinase-like proteins from winter rye are cloned using molecular biology techniques and are expressed in both bacterial and yeast systems.
  • the expressed proteins showed both chitinase and antifreeze activities.
  • the invention includes the DNA and protein sequence of the chitinase-like proteins, any modifications of the said sequences, the expression of these sequences and their application in agriculture, food industry and medicine.
  • the invention is a nucleic acid molecule isolated from a monocot, encoding an AFP.
  • the molecule has the DNA sequence in Figure 21. a, Figure 21.b or Figure 22.a or Figure 22. b.
  • the invention also includes a molecule whose sequence is substantially homologous (homology is discussed below with reference to the amount of sequence identity) to all or part of the DNA sequence in Figure 21. a, Figure 21. b, Figure 22.a or Figure 22.b.
  • the molecule may be selected from a group consisting of mRNA, cDNA, sense DNA, anti-sense DNA, single- stranded DNA and double stranded DNA.
  • the invention also relates to a polypeptide encoded by the nucleic acid molecule and a mimetic of the purified and isolated polypeptide. In a preferred embodiment, the polypeptide has the amino acid sequence in Figure 21. a, Figure 21. b, Figure 21. c, Figure 21.
  • polypeptide in another embodiment, can be substantially homologous to all or part of the amino acid sequence in Figure 21. a, Figure 21. b, Figure 21. c, Figure 21. d, Figure 22.a, Figure 22.b, Figure 22.c or Figure 22.d.
  • the invention also relates to the DNA sequence encoding the signal sequence of the polypeptide that directs its secretion from the cell.
  • the invention includes a molecule whose sequence is substantially homologous to all or part of the DNA sequence in Figure 21. a, Figure 21 .c, Figure 22.b or Figure 22.d.
  • the molecule may be selected from a group consisting of mRNA, cDNA, sense DNA, anti-sense DNA, single-stranded DNA and double stranded DNA.
  • the invention also relates to a polypeptide encoded by the nucleic acid molecule and a mimetic of the purified and isolated polypeptide. In a preferred embodiment, the polypeptide has the amino acid sequence in Figure 21. a, Figure 21. c, Figure 22.
  • the polypeptide in another embodiment, can be substantially homologous to all or part of the amino acid sequence in Figure 21. a, Figure 21. c, Figure 22.b, or Figure 22.d.
  • the targetting sequence may be used to direct protein secretion in a transgenic organism or expression system.
  • the expression host can be a plant, plant cell, algal cell, bacterium, yeast, fungus, animal and animal cell.
  • the invention also includes a system for the expression of a gene encoding a chitinase-like protein, including both an expression vector and cDNA for a chitinase- like protein inserted in the expression vector.
  • the expression vector is E. coli plasmid pET12a.
  • the system consists of Pichia vector pGAPZ ⁇ A.
  • the system includes the chitinase-like DNA sequence in Figure 21. a, Figure 21. b, Figure 22.a or Figure 22.b.
  • the invention also includes a plant, plant cell, animal, animal cell, bacterium, fungus or yeast transformed by the system.
  • Another aspect of the invention includes a method for expressing chitinase-like protein consisting of transforming an expression host with a chitinase-like protein DNA expression vector and culturing the expression host.
  • the expression host can be a plant, plant cell, algal cell, bacterium, yeast, fungus, animal and animal cell.
  • the product of the expression system can be used for producing AFP, increasing freezing tolerance and low temperature disease resistance in plants, animals and microorganisms, inhibition of ice recrystallization in biological matter or food product, cryopreservation of cells, hypothermic protection of cells, cold protection of human platelets and killing tumor cells.
  • the invention also relates to DNA sequences encoding cold-induced endochitinases from all members of Monocots and/or the Poaceae for the same uses as the winter rye sequences described in this application.
  • the invention also relates to organisms (plants, animals and microorganisms) transformed by AFP DNA sequences to promote survival during frozen storage, winter survival and/or freezing tolerance in transgenic organisms.
  • Organisms may be transformed to overproduce the protein, and the AFPs also allow storage of the organisms themselves close to zero Celsius or at a subzero temperature while permitting continued work with them. This is advantageous because many bacterial, animal, plant and yeast cell lines are quite freezing or cold sensitive.
  • nucleic acid molecule isolated from a monocot, encoding an antifreeze protein.
  • nucleic acid molecule comprises the DNA sequence in Figure 21(a), Figure 21(b), Figure 22(a) or Figure 22(b).
  • the nucleic acid molecule may omit the targeting sequence shown in Figures 21 or 22.
  • the molecule preferably has at least 40% sequence identity to all or part of the DNA sequence Figure 21(a), Figure 21(b), Figure 22(a) or Figure 22(b).
  • the molecule is preferably selected from a group consisting of mRNA, cDNA, sense DNA, anti-sense DNA, single-stranded DNA and double-stranded DNA.
  • the invention also includes nucleic acid molecules encoding the same amino acid sequence as the nucleic acid molecules in Figures 21 and 22.
  • the invention also includes a nucleic acid molecule that encodes a chitinase-like antifreeze polypeptide that hybridizes to the nucleic acid molecule of the coding strand from positions 340 to 744 of Figure 22 (a) under a wash stringency of 0.2X SSC to 2X SSC, 0.1 % SDS, at 42°C.
  • Another embodiment of the invention also includes a nucleic acid molecule that encodes chitinase-like antifreeze proteins that hybridizes to the nucleotide sequence of the coding strand from positions 541 to 745 of Figure 21 (a) under a wash stringency of 0.2X SSC to 2X SSC, 0.1% SDS, at 42°C.
  • the invention includes a polypeptide encoded by a nucleic acid molecule of the invention, such as those described in the preceding paragraph.
  • the invention also includes a mimetic of the purified and isolated polypeptide.
  • the polypeptide preferably includes the amino acid sequence in Figure 21(a), Figure 21(b), Figure 21 (c), Figure 21(d), Figure 22(a), Figure 22(b), Figure 22(c) or Figure 22(d).
  • the polypeptide includes at least 40% sequence identity to all or part of the amino acid sequence in Figure 21(a), Figure 21(b), Figure 21 (c), Figure 21(d), Figure 22(a), Figure 22(b), Figure 22(c) or Figure 22(d).
  • a variation of the invention includes a cold-induced antifreeze polypeptide isolated from a monocot or a cold-induced pathogenesis-related protein with antifreeze activity isolated from a monocot.
  • the monocot is preferably from the family Poaceae.
  • the monocot is preferably selected from the group consisting of barley, wheat and rye, spring rye, spring wheat, winter wheat, winter barley, and spring oats.
  • the invention also includes mimetics of these polypeptides.
  • the invention includes an isolated polypeptide having antifreeze activity, selected from the group consisting of barley, wheat and rye, spring rye, spring wheat, winter wheat and winter barley, winter canola, spring oats and kale.
  • the polypeptide is preferably, selected from the group consisting of chitinase, thaumatin and glucanase.
  • the polypeptide is useful for producing antifreeze protein, increasing freezing tolerance in plants and microorganisms, increasing field survival and yields of plants, animals and microorgansims exposed to subzero temperatures, inhibition of ice recrystallization in biological matter or food product, cryopreservation of cells, hypothermic protection of cells, cold protection of human platelets and killing tumor cells.
  • the invention also includes a recombinant DNA comprising a DNA molecule of the invention and a promoter region, operatively linked so that the promoter enhances transcription of said DNA molecule in a host cell.
  • the invention also includes a system for the expression of a chitinase gene, comprising an expression vector and chitinase cDNA inserted in the expression vector.
  • the expression vector preferably includes a plasmid such as an E. coli vector (for example, pET12a).
  • the expression vector may also a Pichia vector (for example pGAPZ ⁇ A).
  • the chitinase DNA preferably comprises all or part of the DNA sequence in Figure 21(a), Figure 21(b), Figure 22(a) or Figure 22(b).
  • the invention also includes a plant, plant cell, animal, animal cell, bacterium or yeast transformed by the system.
  • the invention is a method for expressing chitinase comprising: transforming an expression host with a chitinase DNA expression vector; and culturing the expression host.
  • the expression host is preferably selected from the group consisting of a plant, plant cell, bacterium, yeast, fungus, protozoa, algae, animal and animal cell.
  • the product of the expression system is preferably useful for producing antifreeze protein, increasing freezing tolerance in plants, animals and microorganisms, increasing field survival and yields of plants, animals and microorgansims exposed to subzero temperatures, inhibition of ice recrystallization in biological matter or food product, cryopreservation of cells, hypothermic protection of cells, cold protection of human platelets and killing tumor cells.
  • the invention also includes a nucleotide sequence that targets protein secretion in plants consisting of the targeting sequence of the coding strand or its complement thereof shown in Figure 21 (a), positions 1 through 60.
  • the nucleotide sequence that targets protein secretion in plants preferably includes of the coding strand or its complement thereof shown in Figure 22 (a), positions 1 through 66.
  • the invention includes a method of enhancing antifreeze activity, comprising combining antifreeze polypeptide with sugars to enhance the activity of antifreeze polypeptide to inhibit the recrystallization of ice and modify the normal growth of ice.
  • the invention includes a composition comprising one or more antifreeze proteins combined with one or more sugars.
  • the polypeptides of the invention may be combined with a sugar for a use such as producing antifreeze protein, increasing freezing tolerance in plants and microorganisms, increasing field survival and yields of plants, animals and microorganisms exposed to subzero temperatures, inhibition of ice recrystallization in biological matter or food product, cryopreservation of cells, hypothermic protection of cells, cold protection of human platelets and killing tumor cells.
  • the polypeptides of the invention may be used for inhibition of the initiation or progression of a disease or spoilage caused by a low temperature pathogen in a plant, a frozen food or any cryopreserved biological matter.
  • the invention also includes a method for separating antifreeze proteins from plant materials or recombinant expression systems comprising heating soluble extracts to temperatures of at least about 60°C and then centrifuging or filtering the heated extracts to remove denatured proteins and insoluble materials.
  • the invention relates to an isolated cDNA encoding an antifreeze polypeptide from a monocot.
  • the monocot is preferably from the family Poaceae or the group Triticum (most preferably winter rye).
  • the cDNA preferably also encodes a signal sequence for translocation of the polypeptide.
  • the invention also relates to nucleic acid molecules encoding cold-induced endochitinases from a monocot, the family Poaceae or the group Triticum.
  • the invention also includes polypeptides produced from the nucleic acid molecules.
  • the invention also includes the use of these nucleic the same uses as are described for winter rye and other antifreeze polypeptides in this application.
  • the invention includes an isolated DNA molecule comprising a nucleotide sequence selected from the group consisting of: a nucleic acid molecule shown in Figure 21 or 22, or the complement thereof; a nucleotide sequence that hybridizes to said nucleotide sequence of (a) under moderate or high stringency conditions, for example the conditions described in this application, and which encodes an antifreeze polypeptide; an antifreeze nucleic acid molecule having at least 40%, at least 60%, at least 80%, at least 90%, at least 95%, 97%, 98% or 99% sequence identity with the nucleotide sequence of (a) and which encodes an antifreeze polypeptide; a nucleotide sequence encoding the same amino acid sequence as the nucleotide sequence of (a); and a nucleotide sequence encoding the same amino acid sequence as the nucleotide sequence of (b).
  • the invention also relates to an isolated nucleic acid molecule capable of hybridizing with a nucleotide sequence in monocots under conditions of moderate stringency or high stringency, the sequence encoding a polypeptide having antifreeze activity, and wherein the DNA molecule is capable of hybridizing to a nucleotide sequence of Figure 21 or Figure 22 under conditions of moderate or high stringency.
  • Moderate stringency is used in Examples 25, 25.1 , and 25.2.6.
  • a “higher” stringency may also be used, for example by increasing the temperature to 55 C in example 25.2.2 and to 65 C with the gene-specific probe for CHT46 described in example 26.1.
  • the stringency level used most often 0.2 XSSC, 0.1% SDS, 30 min at 42 C) and the one we claimed for our hybridizationprobes is defined as moderate stringency in Short Protocols in Molecular Biology, F. Ausubel et al., 1995, eds, John Wiley and Sons, Chapter 4, p 25.
  • the invention also relates to a ch9 or ch46 nucleic acid molecule cloned from winter rye and an expression vector comprising the nucleic acid molecule and a promoter controlling expression of the molecule.
  • the invention also includes the expression product of the nucleic acid molecule.
  • the invention also relates to an antifreeze nucleic acid molecule or gene cloned from a monocot from the family Poaceae, preferably winter rye.
  • the invention also relates to a method of delecting the presence of ch46, ch9 or a nucleic acid molecule encoding an antifreeze protein in a sample by a) selecting a probe from the nucleic acid sequences in Figure 21 or Figure 22, b) hybridizing the probe with the biological sample, and c) detecting the presence of a hybridization complex formed by the hybridization of the probe with the ch46, ch9 or antifreeze nucleic acid molecule in the sample, wherein the presence of the complex is indicative of the presence of ch46, ch9 or antifreeze nucleic acid molecule in the sample.
  • the nucleic acid can be DNA or RNA.
  • the probe is preferably at least 75% complementary to a nucleotide sequence of 10 contiguous molecules present in a probe disclosed in this application. Sequences complementary to the probes described in this application are also useful.
  • the invention also relates to a cold tolerant plant having inserted into its genome a recombinant, double-stranded DNA molecule comprising in sequence: • a) a promoter region which functions in plants to cause the production of an
  • RNA sequence operatively linked to
  • the DNA sequence is operatively linked to at least one of a signal sequence and an untranslated sequence.
  • the promoter is preferably heterologous with respect to the DNA sequence and causes sufficient expression of the antifreeze polypeptide in plant cells or tissue to enhance the cold tolerance of a plant transformed with the gene.
  • the nucleic acid molecules of the invention may be used in a method to transform a host cell capable of producing antifreeze polypeptide by transforming a host cell with an expression vector comprising the nucleic acid molecule.
  • the invention also relates to a method for altering the level of antifreeze polypeptide in a cell ( overexpressing antifreeze polypeptide) by transforming a host cell with an expression vector comprising a nucleic acid molecule of the invention and expressing the polypeptide encoded by the nucleic acid molecule.
  • the expression vector preferably includes an antifreeze nucleic acid molecule and a promoter region, operatively linked such that the promoter enhances transcription of said DNA molecule in a host cell.
  • the invention also includes a method of producing a genetically transformed plant which expresses antifreeze polypeptide including the steps of: inserting into the genome of a host plant cell a recombinant, double- stranded DNA molecule comprising: a promoter which functions in plant cells to enhance transcription of an adjacent DNA coding sequence; an antifreeze DNA molecule of the invention operatively linked to the promoter; and regenerating a genetically transformed plant from said host plant cell.
  • the DNA molecule preferably comprises an isolated DNA molecule that is ch9 or ch46 or that hybridizes to a DNA molecule having the ch9 or ch46 nucleotide sequence of Figure 21 or 22, a variant or biologically functional equivalent molecule under conditions of moderate or high stringency.
  • the invention also includes plant produced by the method.
  • the invention also relates to a method for altering the level of antifreeze polypeptide in a plant comprising:
  • DNA comprises an isolated DNA molecule that is ch9 or ch46 or that hybridizes to a DNA molecule having the ch9 or ch46 nucleotide sequence of
  • Figure 21 or 22 a variant or biologically functional equivalent molecule under conditions of moderate or high stringency, wherein said DNA encodes an antifreeze polypeptide
  • the DNA is a nucleic acid molecule is from a monocot from the family Poaceae, preferably winter rye.
  • the molecule may also be from a dicot.
  • the preferably DNA changes the level of endogenous antifreeze polypeptide such that the cold tolerance of the plant is altered relative to the norm for the plant species.
  • the invention also includes a method of providing a cell or plant with low temperature disease resistance (preferably antifungal disease resistance) by transforming a cell or plant with the nucleic acid molecules of the invention and expressing the gene.
  • the method also includes applying a composition including polypeptides of the invention and an agriculturally acceptable carrier.
  • Chitinase, glucanase and thaumatins are all antifungal proteins.
  • the polypeptides of the invention exhibit chitinase, glucanase and thaumatin activity. This activity is retained even when the polypeptides acquire antifreeze activity.
  • the invention also relates to a composition for providing cold tolerance to plants, comprising an antifreeze polypeptide and an agriculturally acceptable carrier.
  • the invention also includes a composition for addition to food products comprising an antifreeze polypeptide and a carrier suitable for human consumption.
  • Antifreeze proteins have many interesting properties. These include the binding and inhibition of ice crystal growth, the inhibition of ice recrystallization and the protection of liposomes, proteins, cell membranes and cells (for a more detailed description, see 111-21 , 111-17). As result, these proteins will find wide application in the food industry to inhibit ice recrystallization to improve the texture, quality and shelf life and reduce losses due to microbial spoilage of the foods, vegetables, fruits, meats and many other food products that are either eaten while frozen or stored in a frozen state. In addition, these proteins can be used in the cryopreservation of cells, embryos, oocytes, tissues (III-4), and hypothermic protection of cells and tissues (III- 44).
  • AFPs in the cold protection of human platelets (III-49). At high concentrations, AFPs also modify the growth of ice in a way that can be used in other biomedical applications to kill certain cells such as tumor cells. In transgenic plants, the AFPs can be used to improve freezing tolerance and increase resistance to low temperature pathogens in the plants expressing these proteins.
  • the novel proteins which we discovered and which are associated with plant freezing tolerance are of 3 categories: i) ice nucleation proteins, ii) antifreeze proteins (AFPs), and iii) polypeptides for enzymatic modification of plant and fungal cell walls.
  • tissue water migrates through the cell walls into the intercellular spaces where the water is allowed to freeze under controlled conditions, resulting in the formation of intercellular ice crystals.
  • the role of the ice nucleation proteins is to initiate ice crystal formation outside the cells in the intercellular spaces in plant tissues.
  • the AFPs are also located extracellularly to bind to and modify ice crystal growth in the intercellular spaces so as to prevent rupture of the cell membranes.
  • the enzymes present in extracellular spaces function to modify cell wall material, which may increase the flexibility of the cell wall material and increase cell viability upon freezing and thawing of the plant tissue. These enzymes may also degrade the cell wall material of low temperature pathogens and provide some resistance to low temperature pathogens.
  • the proteins associated with freezing tolerance are made endogenously by the plant cells and are secreted through the plasma membrane into the intercellular spaces to effect and modify ice crystal formation during exposure to freezing temperatures. It is understood that the make up of the freezing-tolerant proteins may comprise one or more of the identified polypeptides. More than one of the identified polypeptides may combine to provide a protein structure which provides one or more of the noted frost tolerant properties of ice nucleation, antifreeze or enzymatic action.
  • the process is two-step and includes: i) severed or cut leaves are vacuum infiltrated with an extraction buffer preferably containing 20 mM calcium chloride and 10 mM ascorbate, and ii) the infiltrate is extracted from the plant tissue while the cells remain unbroken.
  • the recovered extract exhibits ice nucleation activity, glucanase activity and chitinase activity as well as antifreeze activity.
  • ice nucleation activity can be measured by the droplet freezing assay.
  • the ice nucleation activity decreases upon addition of sulfhydryl reducing agents such as dithiothreitol and mercaptoethanol in the manner to be discussed with respect to the examples.
  • the antifreeze activity of the extract was determined by observing ice crystal growth on a freezing stage mounted on a light microscope. In the presence of the extract, the ice crystals form bipyrimidal and hexagonal structures that indicate modification of crystalline growth.
  • Such structures are similar to those formed in the presence of other types of antifreeze proteins isolated from other sources such as the sea raven fish (li-4). It has been found that the addition of protease to the extract eliminates the antifreeze activity, thus confirming the presence of AFP(s).
  • the glucanase activity is measured as the enzymatic release of glucose equivalents from soluble laminaran (poly- ⁇ -1 , 3-glucose). The glucanase is more active in the presence of calcium.
  • Chitinase activity is measured as the enzymatic release of glucosamine from colloidal chitin (exochitinase) and from chitin oligomers (endochitinase) [1-10.1].
  • various separation techniques may be employed which remove the infiltrate from the intercellular spaces without rupturing the plant cells. Such techniques include vertically orienting the leaves in a funnel or cone placed inside a centrifuge tube to avoid bending the leaves. The leaves are then centrifuged to recover the infiltrate without rupturing the cells.
  • Other techniques are available for polypeptide extraction. For example, leaves may also be extracted by perfusion with appropriate extraction solutions. The extracellular polypeptides are water-soluble and are found in the total soluble fraction when plant tissues are homogenized. The frost tolerance-inducing polypeptides are beneficial to any type of plant where ice formation occurs.
  • Any plant tissue can, in a variety of ways, be adapted to provide or include these polypeptides so that they can modify ice crystal growth. Plants containing these proteins are more likely to withstand exposure to lower cold or freezing temperatures for longer time periods, survive harsher climates, and have longer growing seasons because they are less affected by spring and fall frosts.
  • AFPs have been shown to inhibit ice nucleation (11-13).
  • any plant tissue can, in a variety of ways, be adapted or provided with AFPs to prevent ice nucleation and promote supercooling of the plant liquids
  • the proteins involved in freezing tolerance as provided by this invention have a variety of uses. A significant use is in the detection of characteristics involved in freezing tolerance in plants. Antibodies have been produced for several of the polypeptides. Other plants can be tested for the presence of similar polypeptides by way of an immunoassay to determine their ability to produce cold-induced AFPs, ice nucleators and enzymes, and to assay their capacity for freezing tolerance. It is also understood that plants could be transformed with genetic information that encodes the subject polypeptides to improve or provide frost tolerance in other types of plants. The polypeptides of this invention may also be applied to plant matter.
  • Suitable carriers for the polypeptides may be used which expedite absorption of the polypeptides into plants, fruit, foods or other biological materials.
  • the AFPs will have to be in an aqueous solution to affect ice formation.
  • a physical method such as vacuum infiltration, perfusion, mixing, blending, and soaking with and without abrasion.
  • the polypeptides can be applied by spraying techniques to avoid frost damage to vegetable crops, fruit crops and the like when ambient temperatures drop suddenly below freezing temperature.
  • the polypeptides would be useful in the cryopreservation of biological tissues.
  • Polypeptides also have a broad application in improving the quality of all frozen foods and, in particular, ice cream and other foods that are eaten while frozen.
  • polypeptides of this invention produce a minute crystalline structure in the ice and decreases recrystallization to produce a higher quality product.
  • the polypeptides of this invention are useful whenever it is desired to inhibit recrystallization of ice particles. Such inhibition of recrystallization maintains small ice crystal size, preventing damage to cell walls and membranes and maintaining viability of stored cells and tissues. Further aspects of the invention will be understood based on the following specific discussion and exemplification of the invention.
  • Example 1 Extraction and quantification of extracellular proteins
  • the pots that remained in the growth chamber at 20 °C for another three weeks are control or nonacclimated rye plants (RNH).
  • Rye plants that were grown at 5:2 °C (day:night) (8 h day: 16 h night) for exactly seven weeks and then were shifted to the growth chamber at 20° C for four days are referred as deacclimated (Deacc). All plants were watered with modified Hoagland nutrient solution as described by Huner and Macdowall (I-6).
  • Extracellular proteins were extracted from the leaves of RNH, RH, RH-SD and Deacc plants.
  • the extracellular extracts were prepared by vacuum infiltration of the leaves with 5 mM EDTA, 10 mM ascorbic acid, 10 mM mercaptoethanol, 1 mM phenylmethyl sulfonylfluoride, 2 M caproic acid and 2 mM benzamidine.
  • the vacuum infiltration is in accordance with the process described in Mauch and Staehelin (1-16).
  • the treated leaves were packed vertically in a funnel placed in a centrifuge tube to avoid bending the leaves. With the leaves packed in the funnel, the material was centrifuged to remove the extracellular infiltrate that is captured in the centrifuge tube as an extract. The extract is obtained without rupturing the cells of the leaves.
  • Extracellular proteins were extracted from RNH, RH, RH-SD and Deacc rye leaves, as outlined above in "Protein Extraction”. Protein concentrations in the extracts were determined by the Bio-Rad method with BSA as the standard, using at least four independent replicates. The amount of proteins extracted from the extracellular space varies with the growth conditions of the plants. Nonacclimated leaves have an average extracellular protein content of 0.034 mg protein/g fresh weight. Leaves grown at 5° C with a 16-hour or 8-hour daylength have an average extracellular protein content of 0.149 mg/g fresh weight, or 0.307 mg/g fresh weight, respectively. Thus there is a nine-fold increase in extracellular protein contents in rye plants grown at low temperature with a short daylength. These protein levels decreased when the leaves were shifted back to 20°C to acclimate ( Figure 1).
  • the extracellular proteins were precipitated from extracellular extracts for purposes of electrophoresis by the addition of 1.5 volumes of 1% acetic acid in methanol and incubating overnight at -20°C.
  • the protein pellet was washed with 100% ethanol and 70% ethanol at 5°C and then dried in a desiccator.
  • the protein was resuspended in Laemmli (1-10) sample buffer [60 mM Tris-HCI , pH 6.8; 10% glycerol; 2% sodium dodecyl sulfate (SDS); 5% mercaptoethanol] and separated by electrophoresis, along with Biorad unstained standards, on 10% acrylamide gels using 90 V for the stacking gel and 110 V for the separating gel (1-10).
  • the gels were stained with Coomassie blue.
  • proteins present in column fractions of the extracellular extracts were solubilized directly in Laemmli sample buffer (1-10) and separated by electrophoresis, along with Biorad prestained standards, on 13.5% acrylamide gels at 200 V. The gels stained with ammoniacal silver.
  • the protein profile of extracellular extracts shows remarkable changes between the different types of leaves.
  • SDS-PAGE (10% acrylamide gels) revealed the presence of at least 12 polypeptides in the extracellular extracts.
  • Increases of eight polypeptides with molecular masses of 36, 33, 30, 25, 21 , 15, 14 and 13 kD were observed in extracellular fluids from acclimated leaves ( Figure 2).
  • Increases in two polypeptides with molecular masses of 23 and 20 kD were observed only in leaves cold-acclimated with a short day.
  • Leaf extracellular proteins were concentrated ten-fold by uitrafiltration through an Amicon minicon (1-13). Concentrated extracts were used in the droplet freezing technique to determine the spectrum of active ice nuclei within a given temperature range.
  • Table 5 extracellular extracts from cold-acclimated rye leaves grown under a short photoperiod nucleate ice at -9°C, whereas extracts from cold-acclimated rye leaves grown under a long photoperiod nucleate ice at -10°C.
  • the extracts from nonacclimated and deacclimated leaves initiate ice formation at the lowest temperature (-13° C).
  • the low threshold temperature for nucleation shows that the ice nucleators present in the extracts are not intact ice nucleation sites.
  • Extracellular extracts prepared in accordance with the above technique were evaluated with respect to antifreeze activity.
  • the antifreeze activity was assayed by observing the morphology of ice crystals formed in the extracts using a nanoliter osmometer (Clifton Technical Physics, Hartford, N.Y., U.S.A., II-3, II-5).
  • a-axes the basal plane of the crystal lattice with little growth perpendicular to the basal plane (the c-axis), so that the ice crystals appear flat and round (II-5) (Fig. 6A).
  • nM concentrations of AFPs preferentially inhibit the a-axis growth of ice so that the hexagonal prism faces of the crystal are expressed (11-6) (Fig. 6G).
  • ⁇ M concentrations of AFPs the crystals grow predominantly along the c-axis to form hexagonal bipyramids (II- 6)(Fig. 8C).
  • AFPs in freezing-tolerant plants and organisms are to prevent the recrystallization of ice (11-10). Although ice may initially form as small crystals, these crystals can amalgamate into larger ice crystals over time and cause mechanical damage to the tissue in the absence of AFPs. Recrystallization was assayed by the "splat assay" where a small volume of an extracellular extract was dropped onto a surface at -20°C to form a thin layer of small ice crystals. The splat was then annealed at -8°C for 6 hours.
  • Extracellular extracts were concentrated five-fold, exchanged into 50 mM NH 4 HCO 3 by uitrafiltration (Centriprep-10, Amicon Canada Ltd., Oakville, ON, Canada) and applied to a Sephacryl 200 (Pharmacia LKB Biotechnology, Uppsala, Sweden) column (0.5 x 32 cm) in 50 mM NH 4 HCO 3 .
  • the eluate was monitored for UV absorbance at 280 nm (O - O) and 230 nm (v -v). Protein standards were eluted separately to estimate protein size.
  • Example 8 ice nucleation activity of fractionated extracellular polypeptides
  • Example 9 Thermal hysteresis of fractionated extracellular polypeptides AFPs lower the freezing temperature of a solution noncolligatively by binding to ice crystals and inhibiting crystal growth, but the proteins alter the melting temperature of the solution only by colligative effects (II-5).
  • This thermal hysteresis (the difference between freezing and melting temperatures) is determined by observing the effect of temperature on the growth of a single ice crystal. Melting occurs when faces of the ice crystal become round; freezing occurs when the ice crystal elongates along its c-axis (11-5).
  • winter rye leaves produce AFP(s) that has(have) the ability to modify the normal growth pattern of ice and to depress the freezing temperature of a solution noncolligatively.
  • the thermal hysteresis exhibited by the winter rye AFP(s) is smaller than that observed for other AFPs found in polar fish (approximately 0.6°C, II-7) or in insects (5°C, II-7, II-8). This may be due to the fact that the AFPs from winter rye are not completely purified or to a difference in structure and function.
  • Example 10 Antifreeze activity of at least 11 of the extracellular polypeptides
  • Extracellular polypeptides were extracted from winter rye leaves using 20 mM CaCI 2 and 10 mM ascorbate and were separated by SDS-polyacrylamide gel electrophoresis using a Tris-tricine buffer system with no reducing agent (no dithiothreitol) and large (16 x 18 x 0. 15 cm) 12 % acrylamide gels.
  • the polypeptides were visualized in the gels after a 10 min incubation in ice-cold 0.25 M KCl. After washing the gel in distilled H 2 0, the bands were cut and eluted from the gel in 0.1% SDS and 50 mM Tris-HCI.
  • polypeptides were precipitated from the elution buffer in 80% acetone at -20°C, pelleted and air-dried. The polypeptides were then redissolved in 0.1 M NH 4 HC0 3 and assayed individually for antifreeze activity by observing changes in ice crystal morphology. As shown in Figure 10, 8 polypeptides, ranging from 111 to 161 kD in molecular mass, altered the normal pattern of ice crystal growth so that hexagonal ice crystals were formed. The 93 kD polypeptide actually represents a group of polypeptides that exhibit antifreeze activity and are in the size range of 93 to 99 kD in the Tris-tricine gel system.
  • polypeptides are distinguished by the fact that they stain a reddish-purple color with Coomassie brilliant blue.
  • polypeptides were separated using a Tris- glycine buffer system and either 12.5% gels or gradient gels, and so the sizes of the polypeptides are somewhat different in this system compared with those of the earlier gels.
  • polypeptides with antifreeze activity show that they are relatively enriched in glycine, asparagine or aspartate, alanine, glutamine or glutamate and serine (see Table III for all of the polypeptides) but do not contain hexosamines (within the limits of detection by amino acid analysis after 4 h hydrolysis of 15 picomoles of each polypeptide). None of the polypeptides exhibits the high alanine content characteristic of antifreeze giycoproteins and type I AFPs (11-10). Instead, the rye polypeptides exhibit high hydrophilic amino acid contents, as observed in sea raven and ocean pout (II— 4), and also contain the high glycine content observed in some insect AFPs (ll-17,Table III).
  • Example 12 Identification of chitinase-like proteins in extracellular extracts by immunoblotting
  • Extracellular polypeptides were separated by SDS-PAGE and electroblotted onto nitrocellulose.
  • the blots were probed with primary antibodies to chitinase obtained from Dr. Michel Legrand, Laboratoire de Virologie, Institut de Biologie Moleisme et Cellulaire de la Recherche Scientifique, 15, rue Descartes, 67000 France (1-10.1).
  • the blots were probed with a secondary antibody (anti- rabbit IgG conjugated with alkaline phosphatase) for visualization.
  • the results show that two extracellular polypeptides, 27 and 32 kD, have an epitope similar to that of chitinase (Figure 11).
  • the 27 kD polypeptide is expressed at higher levels in cold- acclimated leaves than in nonacclimated leaves, whereas the 32 kD polypeptide is induced by low temperature.
  • a second immunoblot is presented as Figure 12. The lanes in this blot represent extracellular polypeptides from winter rye plants grown at 5°C for 2, 5, 6, 7, 8, and 9 weeks, which were probed with the antibody to chitinase.
  • the 27 kD chitinase is not apparent in leaves of 2-week-old plants, but accumulates during the entire 9 week period.
  • the 32 kD chitinase only becomes apparent after the plants have grown at 5 C for 7 weeks. At 9 weeks, both chitinase polypeptides appear as doublets (32 and 31 kD, 27 and 26 kD).
  • Example 13 Role of extracellular polypeptides in freezing tolerance in rye.
  • Partial amino acid sequences for three of the seven major polypeptides shown in lane 4 of Figure 9 were determined.
  • the first 20 amino acids of the N-terminus of the 9 kD polypeptide that exhibits antifreeze activity have been sequenced: NH 2 -ALA-ILE-PHE-CYS-GLY-GLN-VAL-ASN-PRO-ALA-LEU-GLY-
  • the first 16 amino acids of the 11 kD polypeptide are:
  • THR-VAL-PRO-GLY- The first 11 amino acids exhibit 55% homology with a kinase-related transforming protein (listed in the Protein Information Resource under the file names MUSHCK and TVMSHC).
  • the first 30 residues of the N-terminal sequence for the 30 kD protein are as follows:
  • polypeptides were separated by SDS-PAGE using Tris-tricine buffers, eluted from the gels, assayed for antifreeze activity, as shown in Figure 10, and then used for sequence analysis.
  • the N-terminal sequences are as follows:
  • a FASTA search revealed that this sequence has 81 % identity in a 16 amino acid overlap with hevein from the para rubber tree.
  • the sequence also has 88% identity in a 16 amino acid overlap with endochitinase (EC 3.2.1.14) isolated from rice and tobacco, as well as 92% identity in a 14 amino acid overlap with agglutinin from wheat also known as isolectin 11.
  • TLPs thaumatin-like proteins
  • GLPs glucanase-like proteins
  • CLPs chitinase-like proteins
  • Example 15 Glucanase and chitinase activities in extracellular extracts
  • Extracellular extracts of winter rye leaves were obtained using an extraction solution of 20 mM calcium chloride and 10 mM ascorbic acid, pH 3.5.
  • Beta-1 , 3- glucanase activity was measured in extracellular extracts using the dinitrosalicylic reagent to assay the release of glucose equivalents from lamina n (11-1.0).
  • the glucanase assay was optimal under the following conditions: pH 3.5, 1% laminarin, presence of CaCI 2 (as opposed to MgCI 2 or MnCI 2 ), 5°C, and measuring absorbance of 470 nm.
  • the beta-1 ,3- glucanase activity was approximately 312 mg glucose equivalents per mg total protein per hour. The extract did not exhibit beta-1 ,4-glucanase activity when carboxymethylcellulose was used as a substrate.
  • the endochitinase activity (1-10.1) was 115 nmol giucosamine released per gram fresh weight per hour, and the exochitinase activity was 9 nmol giucosamine released per gram fresh weight per hour in winter rye plants grown at 5°C with a short day.
  • Rye plants grown at 20°C exhibited an endochitinase activity of 34 nmol giucosamine released per gram fresh weight per hour and an exochitinase activity of less than 3 nmol giucosamine released per gram fresh weight per hour.
  • Example 16 Characterization of ice nucleation activity in cell suspensions
  • Suspensions of single mesophyll cells were obtained from 20°C and 5°C winter rye leaves by pectolytic degradation of the leaf tissue and purification using density gradients.
  • dilution series of the single cell suspensions were assayed for ice nucleation activity using the droplet technique.
  • the mean threshold ice nucleation temperature for mesophyll cells isolated from 20°C and from 5°C leaves was not significantly different and averaged -7.3°C (Tables IV and V).
  • composition of the ice nucleators from leaves of plants grown under different conditions was determined by incubating single cells in the presence of compounds and enzymes known to affect proteins, sulfhydryl groups and disulfide bonds associated with proteins, carbohydrates and phospholipids (Table IV). Treating cells with 3 M urea and heating to 90°C denatures proteins and dramatically decreased ice nucleation activity. Nonspecific proteases (Pronase E and Proteinase K) also decreased ice nucleation activity. Thus the ice nucleators associated with winter rye mesophyll cells have a proteinaceous component.
  • Example 17 Antibodies to the polypeptides with antifreeze activity
  • Polyclonal and monoclonal antibodies were prepared for polypeptides present in extracellular extracts from cold-hardened winter rye leaves. Individual polypeptides separated by SDS-PAGE and electroeluted from gels (using Bio-Rad Prep Cell) were used as antigens.
  • the antibodies are purified and used for immunopurification of the polypeptides in order to determine the ice nucleation, antifreeze and glucanase or chitinase activities of each. Furthermore, the antibodies are used for immunoassays of the polypeptides. The procedures for antibody production and purification, immunopurification of antigens, and immunoassays are described in detail by Harlow and Lane (11-8.1).
  • the detection and quantification of these polypeptides can be used in selection programs designed to decrease plant injury and yield losses caused by freezing temperatures. Previous selection programs have relied on winter survival to increase frost tolerance in overwintering crops and have been unsuccessful. Because of their sensitivity, the immunoassays provide a nondestructive means for selecting plants that have high concentrations of polypeptides associated with either freezing avoidance (presence of AFP and absence of ice nucleators) or freezing tolerance (presence of ice nucleation, antifreeze and glucanase proteins). Antibodies are also used to identify and isolate antifreeze proteins from other plants. Furthermore, these antibodies may be bound to the AFP(s) to enhance their antifreeze activity.
  • Example 18 Antifreeze activity in crude extracts and different plant organs
  • Example 19 Different species and cultivars having antifreeze activity Sixteen different species or cultivars including both monocots and dicots (see
  • Table IV were grown at 5/2°C (day/night temperature) with a 16 hour daylength. Leaves from all sixteen plants were extracted by vacuum infiltration followed by centrifugation using a solution of 20 mM MgCI 2 and 10 mM ascorbic acid, pH 3.5. All sixteen intercellular extracts exhibited the ability to modify the normal pattern of ice crystal growth, although this ability varied between cultivars and species. Of the plants tested, winter rye (Secale cereale cv. Musketeer), periwinkle (Vinca minor), winter wheat (Triticum aestivum cv. Karat and Ruby) and winter barley (Hordeum vulgare cv.
  • polypeptides are synthesized at low non-freezing temperatures, namely those of lane 4 of Figure 9 and Figure 10 ranging in molecular weight from 5 kD to 36 kD and the additional polypeptides of 60, 68 kD, 93 to 99 kD and 16 kD.
  • these polypeptides along with the other polypeptides of this invention exhibit recrystallization inhibition activity at very low concentrations.
  • the polypeptides are useful in production of frozen foods and cryogenic storage of biological tissues. Treatment of frozen foods with the polypeptides can ensure superior food quality upon thawing of the product. Also, with the manufacture of products such as ice cream as well as in the cryopreservation of biological tissues it is desirable to have a minute crystalline structure.
  • the use of the AFPs in limiting crystalline size and in preventing recrystallization are very useful in providing a superior product and reducing storage costs.
  • the amount of polypeptides used in these biological matter and food compositions is minimal, as demonstrated in the examples. For example, an effective amount of the polypeptide may be as little as 25 ⁇ g of the polypeptide per litre of water contained in the biological matter or food product.
  • plants were harvested to provide nonacclimated tissue or transferred to low temperature (5/2°C) with an 8-hour daylength for 7 weeks of cold acclimation.
  • Spring oats (Avena sativa L. cv. Ogle), winter canola (Brassica napus cv. Ceres), kale (B. oleracea var. acephala cv. Dwarf Blue Curled) and tobacco (Nicotiana tabacum L.) were planted in Pro-Mix and grown at 23°C with a daylength of 16 hours until they were large enough to provide sufficient leaf material for the experiments. Plants were then either harvested to provide nonacclimated tissue or transferred for cold acclimation as described above for 7 weeks.
  • Extracellular extracts from leaves of winter barley, winter and spring wheat, winter and spring rye, spring oats, spinach, winter and spring canola, and kale were assayed for antifreeze activity (Fig. 15). Antifreeze activity was not detected in any of the nonacclimated plants as only flat, circular ice crystals formed in the extracellular extracts (Fig. 15). After cold acclimation, the leaves of all spring and winter cereals tolerated freezing temperatures in the range of -10 to -27°C, and all exhibited antifreeze activity. Antifreeze activity was detected in cold-acclimated winter rye, winter wheat, winter barley, spring rye, spring wheat and spring oats, winter canola and kale.
  • antifreeze activity is present in extracellular extracts of the leaves of all freezing-tolerant monocotyledons examined in this experiment, which included all the members of the Poaceae family (winter rye, winter wheat, winter barley, spring rye, spring wheat) that were examined (Fig. 15, Tab. 1).
  • LT50 Freezing tolerance
  • Example 22 Immunodetection of AFPs in various cold-acclimated plants
  • Equal amounts of extracted extracellular proteins were separated in 15% SDS polyacrylamide gels according to Laemmli (1970). Dilute extracts were concentrated by uitrafiltration and the polypeptides were electrophoresed and stained either with Coomassie brilliant blue or silver stain (Bio-Rad). For immunoblotting, proteins were transferred onto 0.45- m nitrocellulose membranes (Bio-Rad) using the Mini Trans-Blot cell (Bio-Rad) according to manufacturer's instructions. The blots were blocked in a buffer of 25 mM Tris-HCI (pH 7.6), 140 mM NaCI, 0.01% (v/v) Tween-20 and 5% (w/v) skim milk powder.
  • Antisera against the winter rye GLP and TLP were used in a 1:10 000 dilution, and antiserum against the winter rye CLP was diluted 1 :1000 for overnight incubation as described by Antikainen et al. (1996).
  • the immunoreaction was detected by alkaline phosphatase-conjugated goat anti-rabbit IgG (Sigma Chemical Co., St Louis, MO, USA) with 5-bromo-4-chloro-3-indolylphosphate-toluidine salt (BCIP; Sigma) and nitro blue tetrazolium (NBT; Sigma) as substrates.
  • Extracellular proteins from winter rye cv. Musketeer were separated and transferred as positive controls on all immunoblots.
  • the distribution of the cold-specific wheat protein WCS120 is similar but not identical to the distribution of cold-induced AFPs (III-24). WCS120 is found in winter wheat, winter rye and winter barley, but it was not detected in oats or in freezing- sensitive maize and rice or in freezing-tolerant dicotyledons such as winter canola (III-24).
  • Example 23 Role of extracellular sugars in modifying the growth of intercellular ice Plants may also use secreted sugars for modifying the growth of intercellular ice.
  • the extracellular extracts were subjected to hydrolysis in concentrated sulfuric acid, so that the assay probably measured both monosaccharides present in the extracts and monosaccharides released by hydrolysis from polysaccharides and glycosylated proteins.
  • sugar to antifreeze protein in order to decrease the amount of antifreeze protein needed to be effective or to enhance or complement the activity of antifreeze proteins.
  • a composition including one or more types of sugar and one or more types of antifreeze proteins is useful for the same purposes as one or more antifreeze proteins alone.
  • Suitable sugars include fructose, glucose, sucrose or fructans (fructose polymers).
  • fructose and other sugars may be added to ice cream before, at the same, or after one or more types of antifreeze proteins are added to the ice cream in order to increase antifreeze protein activity.
  • Example 24 Purification of winter rye antifreeze proteins by heating
  • Example 1 The heat stability of winter rye AFPs was determined to simplify purification procedures. Winter rye and winter wheat leaves were grown at cold temperatures as described in Example 1. Whole leaf extracts were obtained by homogenizing leaf and/or crown tissues in an aqueous buffer containing 20 mM ascorbic acid and 20 mM CaCI 2 or in a buffer containing 20 mM ammonium bicarbonate, and extracellular extracts were obtained as described in Example 1. Whole leaf and extracellular extracts were heated to either 60°C for 30 min or to 100°C for 10 min and the denatured proteins and particulate matter were removed by centrifugation.
  • Antifreeze activity measured as ice crystal modification, was present in the supernatant of whole leaf and extracellular extracts ranging in pH from 3 to 8 of winter wheat and winter rye both before and after heating.
  • the heated extracts were examined by SDS-PAGE, which revealed that the glucanase-like and thaumatin-like proteins were still soluble after heating (Fig. 26).
  • This technique is useful with recombinant proteins as well to simplify purification. This technique is also useful with the other polypeptides or fragments of polypeptides described in this application.
  • the invention includes a method for separating antifreeze proteins from plant materials or recombinant expression systems comprising heating soluble extracts to temperatures of at least about 60°C and then centrifuging or filtering the heated extracts to remove denatured proteins and insoluble materials.
  • EXAMPLE 25 Isolation of cDNAs for Chitinase-like AFPs The goal of this project was to isolate chitinase cDNAs and determine which ones encoded the chitinase-like AFPs.
  • Those skilled in the art believed that cloning chitinases with antifreeze activity would be difficult because plant genomes contain families of genes encoding chitinases. It was also thought that only a minor modification of a protein is required in some cases to confer antifreeze activity, so that it would be difficult to distinguish a chitinase without antifreeze activity from a chitinase with antifreeze activity.
  • Genomic DNA was extracted as described with modifications (III-42). Leaves and crown tissue were collected from 8 day-old rye plants, frozen in liquid nitrogen and ground to a powder in a mortar and pestle. The tissue was added to 5 mL of 60°C extraction buffer (100 mM Tris, 1.4 M NaCI, 20 mM EDTA, pH 8.0, 2%(w/v) CTAB, 0.3% (v/v) 2- mercaptoethanol added before use) and 50 mg PVP were added.
  • 60°C extraction buffer 100 mM Tris, 1.4 M NaCI, 20 mM EDTA, pH 8.0, 2%(w/v) CTAB, 0.3% (v/v) 2- mercaptoethanol added before use
  • the solution was incubated at 60°C with shaking for 1 hr, cooled to room temperature, and extracted with 6 mL chloroform:octanol (24:1). After centrifugation at 3000 rpm for 20 min, the top layer was extracted again with 6 mL chloroform:octanol.
  • the DNA was precipitated by adding 0.5 vol 5 M NaCI and 2 volumes of 95% EtOH and incubating for 30 min at 4°C and 10 min at -20°C. After centrifugation, the pellet was washed twice with 70% EtOH, dried and resuspended in TE buffer (10 mM Tris-HCI, pH 8.0, 0.1 mM EDTA).
  • DNA was treated with RNase A and proteinase K, then extracted with twice with phenol:chloroform:IAA (25:24:1), and precipitated with 0.1 volume 3 M NaOAc, pH 5.2 and 2 volumes of 100% EtOH at -20°C. After centrifugation, the pellet was washed twice with 70% EtOH, dried and resuspended in 200 ⁇ L TE.
  • Total genomic DNA from 8-day-old nonacclimated winter rye leaves and crowns was digested with Bam HI, Eco Rl, Hind III, Xba I or Xho I restriction enzymes. The fragments were separated by agarose gel electrophoresis and transferred to a nylon membrane.
  • a basic barley chitinase cDNA, pHvcht2a which is known to be pathogen-inducible, was used to identify chitinase genes.
  • the membrane was hybridized to pHvcht2a at two different conditions of stringency : 30 or 50% formamide with 6 X SSC at 42°C, and washed to 0.2 X SSC and 0.1% SDS at 42°C, after which it was exposed to autoradiograph film (Fig. 3B).
  • At least three genes were present under high stringency (50% formamide) as three DNA fragments in each of the Eco Rl, Hind III and Xba I lanes hybridized with the pHvcht2a probe. There were two bands in the Bam HI lane under high stringency.
  • pHvcht2a A basic barley chitinase cDNA, pHvcht2a, which is known to be pathogen- inducible, was used to screen the cold-acclimated rye leaf cDNA library.
  • the sequence for pHvcht2a is a 1028 bp insert in the Eco Rl site of pBluescript SK+. Eco Rl was used to isolate the fragment for use as a probe. The size of the fragment used as a probe is 915 bp because the insert has an Eco Rl restriction site near the 3' end of the cDNA.
  • pHvcht2a encodes a chitinase that has the highly conserved chitinase catalytic domain but lacks the chitin-binding domain.
  • the membrane was hybridized with pHvcht2a under high stringency conditions (50% formamide, 6 X SSC, 42°C) and washed to 0.2 X SSC and 0.1% SDS at 42°C.
  • the blot was exposed to autoradiograph film, which revealed mRNA that hybridized to the probe.
  • Two different chitinase mRNAs were identified with sizes of 1.25 and 1.00 kb.
  • the 1.25 and 1.00 kb transcripts corresponded to the predicted transcript sizes for the 35 and 26 kD chitinase-like AFPs, respectively.
  • the probe pHvcht2a was used to screen the ⁇ Zap-cDNA library made from poly A + RNA isolated from cold-acclimated rye leaves to identify full-length chitinase cDNAs as described below.
  • Total RNA was extracted from tissues as previously described (III-33) with modifications. Plant tissue was ground in a mortar and pestle while frozen by liquid nitrogen. Z6 buffer (8 M guanidine hydrochloride, 20 mM MES pH 7.0, 20 mM EDTA) and 200 ⁇ L 2-mercaptoethanol were added to the tissue, which was further homogenized while frozen. The slurry was mixed with 1 vol of phenol: chloroform: isoamyl alcohol (25:24:1) to extract the proteins.
  • RNA was pelleted by centrifuging the solution at 8000 xg for 45 min. The pellet was washed 2 times with 70% EtOH, dried and resuspended in DEPC-treated H 2 0. The RNA was precipitated using 8 M LiCI at -20°C. The RNA was pelleted by centrifuging at 8000 rpm for 45 min and washed two times with 70% EtOH.
  • the pellet was dried and resuspended in DEPC-treated H 2 O.
  • Poly A+ mRNA was isolated from total RNA using the PolyATtract mRNA Isolation system (Promega, Madison, WI, USA).
  • the poly A+ RNA was made into a cDNA library using the ⁇ ZAP-cDNA Gigapack Cloning Kit (Stratagene, La Jolla, CA, USA).
  • the membranes were prehybridized in 50% formamide solution containing 6 X SSC, 0.5% (w/v) SDS, 50% (v/v) formamide, 5 X Denhardt's solution (1 X Denhardt's solution is 0.02% (w/v) Ficoll, 0.02% (w/v) PVP, 0.02% (w/v) BSA) and 100 mg mL '1 sheared denatured salmon sperm DNA at 42°C for at least 3 hr. The blots were hybridized at 42°C overnight with the barley chitinase cDNA probe (pHvcht2a,1028 bp) provided by Dr.
  • Pvu II restriction enzyme digests were performed on each of the reconstituted pBluescript plasmids to release the inserts and to determine the size of the insert.
  • the pBluescript plasmid has two Pvu II cutting sites, 445 bp apart, which flank the multi-cloning site. Digestion with this enzyme releases the insert and adds 445 bp to the actual size of the insert.
  • the plasmid size appears to be 2500 bp on an agarose gel with the insert appearing as the other band. If the insert itself contained any Pvu II restriction sites, more than two bands would appear in total, with the 2500 bp representing the plasmid and the other bands totalling the insert size.
  • G-tracking analysis was performed on the clones to determine which clones were the same and thus redundant.
  • the G reaction of the Sanger sequencing reaction was performed for each clone using T3 and T7 sequencing primers and separated by polyacrylamide gel electrophoresis. The banding pattern of each clone was compared with one another within a primer group. G-tracking allows some sequence data to be obtained and indicate which clones are the same. There were eight groups of clones with nine clones having no match with any other clone.
  • Preliminary sequencing analysis was performed on some of the clones that were predicted to be full-length based on the Pvu II restriction data. Representative clones of groups that had inserts bigger than 950 bp were chosen. The clones were sequenced initially using the T3 and T7 universal primers. From the data, sequence strategies were made to obtain further sequence data. Some of the sequences revealed restriction sites that would allow a part of the insert to be deleted from the plasmid. After the deletion was made, the plasmid was religated and sequenced using the T3 or T7 primer to get more sequence data. In some cases this was not possible and primers were designed from the sequence data to continue sequencing.
  • the pCHT9 insert was determined to have the same predicted N-terminal amino acid sequence as the one determined for the 35 kD chitinase-like AFP determined by N-terminal sequencing (III-23).
  • the pCHT46 insert was also determined to be full-length.
  • the translated gene product has the same size as the 26 kD chitinase-like AFP and appears to have the longest 5' untranslated region when compared to other members of its group.
  • the predicted N-terminal amino acid sequence of the translated gene product is very similar to the pHvcht2a predicted amino acid sequence. Both clones have an ATG start codon and contain open reading frames (ORF) that follow amino acid sequences consistent with known chitinases.
  • the sequence of CHT9 was determined in both directions using the ALFexpress DNA sequencer at the Sick Children's Hospital Biotechnology Service Centre, (University of Toronto, Toronto, ON, Canada) with various plasmid constructs and primers designed against the initial and growing sequence data.
  • the cDNA was determined to be 1193 bp in length with a poly A tail (Fig. 21).
  • the ORF contained 318 amino acids that began with the methionine codon 48 bp downstream from the 5' terminus of the insert and ended with the stop codon 955 bp from the ATG start codon.
  • the predicted first amino acid in the gene product is glutamate at position 21 of the ORF as the N-terminal amino acid sequence data for the 35 kD chitinase-like AFP is known.
  • the predicted gene product consists of 301 amino acids with a molecular weight of 31647 Da and a pi of 6.96. There were 190 bp of noncoding region at the 3' terminus. PSORT analysis was performed on this cDNA and predicted that there was a 20 amino acid signal sequence that targets the protein to the outside of the cell (Fig. 21 ( c).
  • the invention also includes variants of this signal sequence which are biologically functional equivalent peptides, polypeptides and proteins of the signal sequence (or the encoding nucleic acid molecule) that exhibit the same or similar signal targeting activity this signal sequence.
  • variants with respect to antifreeze polypeptides, below, also applies to the signal sequence by itself.
  • the signal sequence is easily attached to other polypeptides besides antifreeze polypeptides for targeting them outside of the cell.
  • the invention also includes a method for translocating a polypeptide, peptide or protein outside of a cell by expressing recombinant DNA, using protein synthesis or other techniques known in the art to produce a polypeptide, peptide or protein fixed to the signal sequence (or biologically functional equivalent) such that the polypeptide, peptide or protein is translocated of of cell.
  • CHT46 was determined to encode for a full-length chitinase that could encode the 26 kD chitinase-like AFP and was sequenced completely (Fig. 22). CHT46 was shown to have a 998 bp insert that had 78 bp upstream from the first ATG that initiated the ORF of 252 amino acids.
  • the predicted gene product has a molecular mass of 26835 Da and a pi of 8.25.
  • the stop codon is located 757 bp from the ATG start codon with 163 of 3' untranslated region.
  • PSORT also predicted that this protein has a 22 amino acid sequence (Fig. 22(d) and is targeted to the outside of the cell. 25.2.6 Sequence comparison of CHT9 and CHT46
  • CHT9 is 82.2% identical to the rye seed chitinase with 86.6% similarity in amino acids.
  • CHT46 is only 57.4% identical to the rye seed chitinase with 62.2% similarity in amino acids.
  • cDNA probes were designed to identify chitinase-like AFPs.
  • One 404 bp probe (ch46hp) consists of a sequence complementary to the sequence of CHT46 beginning at nucleotide 340 and ending at nucleotide 744 (Fig. 22(b).
  • a second 404 bp probe (ch9hp) is a sequence that complements the homologous region in the CHT9 sequence beginning at nucleotide 541 and ending at nucleotide 945 (Fig. 21(a). Variants of the nucleotide sequence of the probes (biologically funtionally equivalent probes) are also useful.
  • the DNA or RNA in question is transferred to a membrane.
  • a membrane Preferably, following prehybridization at 42°C using 50% formamide, 6X SSC, 0.5% SDS, 5X Denhardt solution (a 1X solution is 0.02% w/v Ficoll, 0.02% w/v PVP, 0.02% w/v BSA) and100 ⁇ g mL "1 sheared denatured salmon sperm DNA, the DNA or RNA in question is allowed to hybridize under the same conditions using either labelled, denatured ch46hp or labelled, denatured ch9hp in place of the salmon sperm DNA.
  • the membranes are preferably washed with 0.2X SSC and 0.1% SPS at 42°C for 30 min.
  • the present invention includes not only the rye chitinase-like AFP encoded by sequences presented in Figures 21 and 22, but also biologically functional equivalent peptides, polypeptides and proteins that exhibit the same or similar antifreeze activity as rye AFPs.
  • the invention also includes nucleotide sequences that are biologically functionally equivalent to CHT9, CHT46, PCHT9 or PCHT46.
  • Example 26 Expression analysis of chitinase CHT9 and CHT46 26.1 Expression in cold- and nonacclimated leaves
  • the gene-specific probe for CHT9 is a 30-mer oligonucleotide: CGAATAATGGTGCAATCCATCGCAAGATGC.
  • the gene-specific probe for CHT46 is a cDNA fragment 292 bp in length, which includes the poly A tail of the transcript (TCGAGTGCGGCATGGGCCGGAACGACGCCAACGTCGACCGCATCGGCTACTA CACACGCTACTGCGGCATGCTTGGCACGGCCACCGGGGGCAACCTCGACTGC TACACCCAGCGAAACTTCGCTAGCTAGACAGTGTATGCACGTGTTATAAATAAAT GGCAATGCATATGCCATCCCCGAATAAATAATTCAACATGTGACAGTTGATTTGT ATGGTAATACGAGTAAGTTGTTGCAACAAATTATGAATATTGAATAAAATCAAATT TTATCAAAAAAAAAAA).
  • the gene-specific probe for CHT9 hybridized to a 1.25 kb transcript whereas the gene-specific probe for CHT46 hybridized to a 1.0 kb transcript.
  • a higher stringency wash was added (0.2 X SSC, 0.1% SDS at 65°C) to the protocol to reduce the occurrence of unspecific binding due to the poly A tail of the probe.
  • the relative intensities of the bands between nonacclimated and cold-acclimated RNA were determined by densitometry. There was a 2.5-fold increase in signal intensity in cold-acclimated leaves for CHT9 and a 1.3-fold increase in signal intensity in cold-acclimated leaves for CHT46 when compared with nonacclimated leaves.
  • Rye tissues were sampled during cold-acclimation. Crown (meristem or dividing tissue), new leaf, old leaf, and root samples were taken after 1 week, 3 weeks, 5 weeks, and 7 weeks at cold-acclimating conditions. Tissues from plants grown for 4 weeks at nonacclimated conditions were used as a control. New leaves appeared only after the plants were transferred to the cold-acclimating temperature. Old leaves were leaves that expanded under nonacclimated conditions before the plant was transferred.
  • CHT9 hybridized to a 1.25 kb transcript that appeared in all of the tissues except the roots.
  • the signal for this transcript has a lower intensity for all of the tissues after 1 week cold-acclimation and progressively increases during the cold acclimation. The signal has the strongest intensity in the crown tissue after 7 weeks of cold-acclimation.
  • the CHT46 gene-specific probe hybridized to a 1.0 kb transcript. The transcript appeared in all of the tissues with low intensity in tissues after 1 week cold-acclimation and gradually increasing intensities over time during cold-acclimation. The CHT46 transcript appears to be present in all of the tissues including the roots.
  • CHT9 a 1.25 kb transcript was present in the 7 week cold-acclimation sample and in the samples taken 6 and 12 hr after being transferred from cold to nonacclimating conditions, after which the signal decreases. There does not appear to be any signal in the other samples.
  • a 1 kb transcript hybridized in all of the samples. The intensity of the transcript signal increased over time during cold-acclimation. The message disappeared slowly after plants were transferred to nonacclimating conditions.
  • Salicylic acid induces expression of genes encoding antifungal chitinases. Rye plants grown at nonacclimated conditions for 2 weeks were sprayed once a day with 20 ppm salicylic acid in 0.5% (v/v) Tween for 8 days. Unsprayed plants were used as controls. Leaf tissue was harvested daily from these plants 1 hr after the salicylic acid treatment and used to isolate total RNA. Expression was analysed by northern blotting using the CHT46 gene-specific probe by using low stringency wash conditions. One kb and 3.7 kb transcripts were apparent in all the samples whether treated or not treated with salicylic acid. The 3.7 kb transcript may result from unspecific binding due to the low stringency washes.
  • CHT9 and CHT46 were cloned into the pKYLX7.1-35S 2 Agrobacterium tumefaciens-compat ⁇ b ⁇ e vector. These vectors were transformed into a disarmed A. tumefaciens strain (C58 pGv3850) by electroporation. These strains were introduced into Arabidopsis thaliana by vacuum infiltration and seeds were harvested from the plants. These seeds were screened for kanamycin resistance and the T1 plants were analyzed for the number of inserts. Plants with one insert of either CHT9 or CHT46 were advanced to homozygosity in the T3 generation.
  • CHT46 and CHT9 in T3 plants are confirmed by Northern blotting using gene-specific probes described in Example 25. Accumulation of chitinase-like AFPs is confirmed by immunoblotting as described in Example 22 and assays of antifreeze activity. Antifreeze activity can be assayed in either crude extracts as described in Example 18 or in extracellular extracts as described in Example 5.
  • Encoding DNA refers to chromosomal DNA, plasmid DNA, cDNA or synthetic DNA that encodes proteins similar to winter rye AFPs or other AFPs of the invention, preferably the chitinase-like AFPs.
  • Encoding DNAs of the present invention may be introduced into microbial, plant or animal host. Microbial hosts include algae, bacteria, fungi and protozoa. Encoding DNAs introduced into a host may be incorporated into plasmids or into chromosomes located in microbes, nuclei and organelles. Overexpression refers to the accumulation of a recombinant protein that is not normally present or is present at a higher level than normally seen in expression of the endogenous gene.
  • Example 28 Expression of CHT9 and secretion of chitinase-like AFP in E. coli 28.1 Cloning of CHT9 into a bacterial expression vector
  • CHT9 was PCR (polymerase chain reaction) amplified with the synthetic oligonucleotides
  • the ca. 800-bp PCR-amplified fragment was digested with BamHI and ligated into the unique BamHI site of pET12a.
  • the ligation mixture was transformed into DH5 ⁇ , plated onto LB-ampicillin (150 ⁇ g/ml) plates, and incubated at 37°C. Plasmids of individual colonies were analyzed to find clones having the BamHI fragment inserted in the correct orientation, i.e. CHT9 reads in the same direction as the secretion signal provided by the vector.
  • the plasmid DNA of ch9/12a was purified from DH5 ⁇ cells by using a QIAGEN DNA purification kit (QIAGEN, Germany) and transformed into the expression host BL-21(DE3) cells from Novagen (Madison, WI) in which a chromosomally inserted T7 polymerase was provided to dictate the expression of the plasmid encoded gene.
  • QIAGEN QIAGEN DNA purification kit
  • a chromosomally inserted T7 polymerase was provided to dictate the expression of the plasmid encoded gene.
  • To express the chitinase-like AFP a single colony was picked from a freshly streaked LB-plate and was used to inoculate a 2 ml LB/ampicillin culture. The culture was incubated with shaking at 30°C for overnight.
  • a 50 ml LB/ampicillin culture was inoculated with 1 ml of the overnight culture in a 250 ml flask and incubated at 30°C with shaking until the OD600 reached 0.4.
  • the IPTG (Sigma) was added to a final concentration of 0.4 mM and the incubation was continued for an additional 3hr.
  • the cells were harvested by centrifugation at 5000 x g for 5 min at 4°C. 28.3 Purification and analysis of the expressed proteins
  • the bacteria cell pellet was resuspended in ice-cold 20% sucrose, 2.5 mM EDTA, 20 mM Tris-HCI pH ⁇ .O to a concentration of 5 OD550 units/ml and incubated on ice for 10 min.
  • the suspension was centrifuged at 15,000 x g for 5 min and the pellet was resuspended in the same volume of ice-cold 2.5 mM EDTA, 20 mM Tris-HCI pH 8.0, incubated on ice for 10 min, and centrifuged as above for 10 min.
  • the supernatant is the periplasmic fraction and was further analyzed by SDS-PAGE and immunoblotting with antiserum raised against the rye chitinase-like AFP (see Example 17).
  • the bacteria expression vector pET12a contains the leader sequence of the ompT (outer membrane protein T) protein, and in some cases, the target proteins may be directed to the periplasmic space.
  • the leader sequence is necessary, but not sufficient for export into the periplasm. Translocation also can depend on the mature domain of the target protein.
  • the osmotic shock protocol is a simple method of preparing the periplasmic fraction from BL-21 cells.
  • Figure 24 shows the expression of the chitinase in cells transformed with pET12a/ch9. Protein extracts from total cells showed a major band of ca. 32 kDa (lanes 2,4) which is absent in the extract of control cells (lanes 1 , 3).
  • the periplasmic fraction contained the expressed protein, the majority of the expressed chitinase-like AFP remained intracellular (data not shown).
  • this fraction was concentrated 1000-fold and the antifreeze activity was monitored by observing changes in morphology of ice crystals formed during freezing. Antifreeze activity was present in this fraction because the ice crystals grew in the shape of hexagonal bipyramids with straight faces.
  • the recombinant protein also exhibited chitinase activity, which was assayed as described in Example 15.
  • Example 29 Expression and secretion of chitinase-like AFP in Pichia pastoris
  • the Pichia expression vector was purchased from Invitrogen (San Diego, CA). To insert the CHT9 cDNA into the EcoRI and Notl site of the expression vector pGAPZ ⁇ A, CHT9 was PCR-amplified with the synthetic oligonucleotides
  • the DNA sequence of the recombinant plasmid was confirmed by DNA sequencing as described above.
  • the His/Myc tag strategy is useful for producing active chitinases and other antifreeze proteins. Therefore the invention also includes a method of purifying chitinases and other antifreeze proteins. Tags similar to the His/Myc tag may also be used for purification. 29.2 Cloning of a CHT9 construct without the c-terminal tag
  • a new oligonucleotide 5'-TCTGGAGACTATGCGAACGGCCTCTTGGTT-3' was synthesized, and together with the 5'-oligo described above, were used in a PCR reaction to generate EcoRI and Xbal as the 5' and 3' ends of CHT9, respectively.
  • the amplified fragment was digested with EcoRI and Xbal and ligated into the pGAPz ⁇ A restricted with the same enzymes.
  • Such a strategy ensures that the sequences of the His/Myc tag encoded by the vector are not attached to the C- terminus of CHT9.
  • the selection and amplification of the recombinant plasmid were carried out as described above.
  • the positive clone was named pGAPz ⁇ A/cht9(-tag) and is useful for increasing antifreeze activity in the recombinant protein.
  • Plasmid DNA of pGAPZ ⁇ A/cht9 and pGAPZ ⁇ A/cht9(-tag) was purified by using a large scale DNA purification kit (QIAGEN, Germany). Approximately 10 ⁇ g of the plasmid DNA was transformed into the yeast cells X-33 (Invitrogen) by electroporation (Bio-Rad GenePulser) according to the parameters recommended by the manufacturer's protocols. The transformed cells were incubated at 30°C on
  • YPDS plates (1 % yeast extract, 2% peptone, 2% D-glucose, 1 M sorbitol, 2% agar) containing 100 ⁇ g/ml Zeocin for 3 days. The colonies were further purified by streaking for single colonies on fresh YPDS/Zeocin plates. Eight of the Zeocin- resistant Pichia transformants for each clone were analyzed for the presence of the
  • CHT9 cDNA The genomic DNA was isolated from individual clones and a PCR protocol was carried out to detect the presence of the insert according to the Pichia Expression Manual (Invitrogen). The clones containing the chromosomally inserted
  • CHT9 cDNA were chosen for expression analysis.
  • a single colony from each recombinant clone was used to inoculate 10 ml of YPD medium (1% yeast extract, 2% peptone, 2% glucose) and the culture was incubated with shaking at 28-30°C overnight. Approximately 0.1 ml of the overnight culture was used to inoculate 50 ml of YPD in a 250 ml flask and the incubation was continued for 2-3 days. At the end of each day, 1 ml of culture was collected, centrifuged, the supernatant and the cell pellet were analyzed by SDS-PAGE and immunoblotting.
  • YPD medium 1% yeast extract, 2% peptone, 2% glucose
  • the pGAPZ ⁇ A (2.9 kb) vector uses the GAP promoter to constitutively express recombinant proteins in Pichia pastoris.
  • GAP is the promoter of the GAPDH (glyceraldehyde-3-phosphate dehydrogenase) gene, which is constitutively expressed in many organisms including Pichia pastoris.
  • this vector has an N-terminal peptide encoding the Saccharomyces cerevisiae ⁇ -factor secretion signal, which, in some cases, targets the foreign proteins to the extracellular space (supernatant).
  • Figure 25a shows overexpression and secretion of the recombinant chitinase from the yeast cells.
  • Protein samples prepared from the supernatant of the yeast culture showed a major band in SDS-PAGE of ca. 32 kDa (lanes 1 , 2).
  • Figure 25b shows the immunoblot analysis of the same samples.
  • the majority of the expressed chitinase-like AFP in yeast was present in the supernatant (compare lanes 1 , 2 and 3,4 ), indicating that the secretion was nearly complete.
  • the level of expression and secretion was calculated to be in the range of 50 to 100 mg per liter of culture medium.
  • Pichia pastoris secretes little of its own protein, so the successful secretion of the recombinant chitinase-like AFP ensures easy purification and characterization.
  • an alternative clone was constructed in such a way as to delete the His/Myc tag attached to the c- terminus of the native chitinase.
  • the expression and secretion levels of the recombinant protein are comparable to that of the pGAPZ ⁇ A/cht9.
  • SDS-PAGE and immunoblotting of the expressed proteins from both clones show that the recombinant chitinase-like AFPs have antifreeze activity because hexagonally- shaped ice crystals are formed in the AFP solutions.
  • the recombinant chitinase-like AFPs also exhibit chitinase activity, which was assayed as described in Example 15.
  • CHT46 was also expressed in £ coli as a fusion protein with a leader sequence containing six histidines using the vectors described in Example 27.
  • the recombinant protein was purified from cell lysate, prepared as described in Example 27, using a nickel chelation column. After refolding and cleavage of the His tag, the mature recombinant protein exhibited definite antifreeze activity as hexagonal ice crystals were formed in solutions of the recombinant AFP.
  • Example 32 Enhancement of antifreeze activity
  • the antifreeze activity of the chitinase-like AFP is further increased by carrying out selective site-directed mutagenesis.
  • An example is the increase in AFP activity from the fish Ocean Pout using this approach (III-32).
  • protein modelling and other prediction methods we identify the ice binding domain and other critical amino acid residues in the chitinase-like AFPs that are candidates for mutation, insertion and/or deletion.
  • a DNA plasmid or expression vector containing the chitinase-like AFPs gene is used for these studies using the U.S.E. (Unique site elimination) mutagenesis kit from Pharmacia Biotech or other similar mutagenesis kits that are commercially available.
  • the mutant protein is expressed using any of the expression systems and its antifreeze activity monitored. This approach is useful not only to enhance antifreeze activity, but also to engineer some functional domains for other properties useful in the purification or application of the proteins or the addition of other biological functions. It is also possible to synthesize a DNA fragment based on the sequence of the chitinase-like AFPs that encodes smaller proteins that retain antifreeze activity and are easier to express. It is also possible to modify the expression of the cDNA so that it is induced under environmental conditions other than cold temperatures or in response to different chemical inducers or hormones. It is also possible to modify the DNA sequence so that the protein is targeted to a different location. All these modifications of the DNA sequences presented in Figures 21 and 22 and the proteins produced by the modified sequences are encompassed by the present invention.
  • Example 33 Inheritance of antifreeze proteins in winter and spring wheat.
  • Cheyenne winter wheat (Triticum aestivum L. cv Cheyenne), Chinese Spring wheat (Triticum aestivum L. cv Chinese Spring), and 21 chromosome substitution lines were grown as described in Example 1.
  • one pair of chromosomes in Chinese Spring wheat was replaced by the corresponding homologues from the variety Cheyenne, which has a much higher degree of freezing tolerance.
  • Apoplastic extracts were obtained from leaves of Chinese Spring wheat, Cheyenne winter wheat, and the 21 chromosome substitution lines as described in Examples 10 and 21. Each extract was assayed for antifreeze activity as described in Example 5.
  • the proteins present in the extracts were quantified as described in Example 21 , then separated by SDS-PAGE and examined by immunoblotting using antisera produced against winter rye AFPs with similarity to glucanases, chitinases and thaumatins as described in Example 22.
  • apoplastic extracts from the leaves of Chinese Spring, Cheyenne and the 21 chromosome substitution lines all exhibited antifreeze activity and all contained glucanase-like, chitinase-like and thaumatin-like AFPs (Chun et al, 1998, Euphytica 102:219-226).
  • the amount of apoplastic potein per leaf and the level of antifreeze activity were positively and significantly correlated with the winter survival of all 23 lines.
  • Chromosomes 5B and 5D carry the major genes for both the greater accumulation of apoplastic proteins and higher antifreeze activity.
  • the DNA sequences (also referred to as nucleic acid molecules in this application) of the invention may be obtained from a cDNA library, for example by using the methods of Example 25 (genomic DNA libraries).
  • the nucleotide molecules can also be obtained from other sources known in the art such as expressed sequence tag analysis or in vitro synthesis.
  • the AFP-encoding DNA described in this application (including variants that are biologically functional equivalents) can be introduced into and expressed in a variety of eukaryotic and prokaryotic host cells.
  • a recombinant nucleic acid molecule for the AFPs contains suitable operatively linked transcriptional or translational regulatory elements.
  • Suitable regulatory elements are derived from a variety of sources, and they may be readily selected by one with ordinary skill in the art (Sambrook, J, Fritsch, E.E. & Maniatis, T. (1989). Molecular Cloning: A laboratory manual. Cold Spring Harbor Laboratory Press. New York; Ausubel et al. (1989) Current Protocols in Molecular Biology, John Wiley & Sons, Inc.). For example, if one were to upregulate the expression of the gene, one could insert the sense sequence and the appropriate promoter into the vector. Plant promoters can be inducible or constitutive, environmentally - or developmentally-regulated, or cell - or tissue-specific.
  • promoters known in the art such as the "Super- promoter” [Ni et al., (1995) Plant Journal 7:661-676] or the 35S promoter of cauliflower mosaic virus [Shah et al., (1986) Science 233:478-481.].
  • Inducible promoters include: a) drought- and ABA-inducible promoters which may include ABA-responsive elements [Ono et al., (1996) Plant Physiol 112:483- 491 ; Abe et al., (1997) Plant Cell 9:1859-1868.]; b) heat shock-inducible promoters which may contain HSEs (heat shock elements) as well as CCAAT box sequences [Rieping M and Schoffl F (1992) Mol Gen Genet 231 :226-2321: c) salt-inducible promoters which may include AT and PR elements [Raghothama et al., (1997) Plant Mol Biol 34:393-402]; d) Copper-inducible promoter that includes ACE1 binding sites [Mett et al., (1996) Transgenic Res 5:105-113.]; e) steroid-inducible promoter that includes the glucocorticoid response element along with an expression vector coding for a
  • tissue specific expression is achieved with the use of tissue-specific promoters such as, the Fd (Ferredoxin) promoter that mediates high levels of expression in green leaves [Vorst et al. (1990) Plant Mol Biol 14:491-499.] and peroxidase promoter for root-specific expression [Wanapu & Shinmyo (1996) Ann. NY Acad. Sci. 782:107-114.]. Pollen-, flower-, fruit- and seed-specific promoters can also be used. These promoters vary in their transcription initiation rate and/or efficiency. If one were to downregulate the expression of the gene, one could insert the antisense sequence and the appropriate promoter into the vehicle. These techniques are known to those skilled in the art.
  • the nucleic acid molecule or gene fragment may be either isolated from a native source (in sense or antisense orientations), synthesized, or it may be a mutated native or synthetic sequence or a combination of these.
  • regulatory elements include a transcriptional promoter and enhancer or RNA polymerase binding sequence, a ribosomal binding sequence, including a translation initiation signal. Additionally, depending on the vector employed, other genetic elements, such as selectable markers, may be incorporated into the recombinant molecule. Other regulatory regions that may be used include an enhancer domain and a termination region.
  • the regulatory elements described above may be from animal, plant, yeast, bacterial, fungal, viral, avian, insect or other sources, including synthetically produced elements and mutated elements.
  • the polypeptide may be expressed by inserting a recombinant nucleic acid molecule in a known expression system derived from bacteria, viruses, yeast, mammals, insects, fungi or birds.
  • the recombinant molecule may be introduced into the cells by techniques such as Agrobacterium tumefaciens-me ⁇ ated transformation, particle-bombardment- mediated transformation, direct uptake, microinjection, coprecipitation , transfection and electroporation depending on the cell type.
  • Retroviral vectors, adenoviral vectors, DNA virus vectors and liposomes may be used.
  • Suitable constructs are inserted in an expression vector, which may also include markers for selection of transformed cells.
  • the construct may be inserted at a site created by restriction enzymes.
  • a cell is transformed with a nucleic acid molecule of the invention or a fragment of a nucleic acid molecule inserted in an expression vector to produce cells expressing an AFP.
  • the gene or gene fragment may be either isolated from a native source (in sense or antisense orientations), synthesized, or it may be a mutated native or synthetic sequence or a combination of these.
  • Another embodiment of the invention relates to a method of transforming a cell with the nucleic acid molecule of the invention or a fragment of the nucleic acid molecule, inserted in an expression vector to produce a cell expressing the AFP.
  • the invention also relates to a method of expressing the polypeptides of the invention in the cells. Transformed plant cells are then used to produce tissue cultures, seeds or whole plants. The methods and compounds for producing mature plants from cells are known in the art.
  • Plants (and plant cells) that may be transformed with the AFP nucleic acid molecules or treated with compositions comprising AFPs include asparagus, arabidopsis, potato, tomato, brassica (e.g. canola), cotton, sunflower, strawberries, spinach, lettuce, rice, soybean, rice, corn, wheat, orchard grass, rye, barley, atriplex, salicornia oat, barley, hops, sorgum, alfalfa, sunflower, alfalfa, beet, pepper, tobacco, melon, squash, pea, cacao, hemp, coffee plants, sugar cane, cucumbers and grape vines. Trees may also be transformed.
  • Such trees include maple, birch, pine, eucalyptus, spruce, oak and poplar, as well as fruit trees like peach, nectarine, cherry, apple, pear, plum, apricot, olive, fig, lemon, lime, orange, tangerine and grapefruit.
  • Decorative flowering plants such as carnations and roses may also be transformed with the gene of the invention.
  • Plants bearing nuts such as peanuts, walnuts, pecans, and cashews may also be transformed with an antifreeze protein nucleic acid molecule.
  • Plants used as spices and for herbal and verbal purposes such as ginseng, ginger, gingko, lemongrass, cinnamon, nutmeg, pepper and cumin, may also be transformed with an antifreeze protein nucleic acid molecule.
  • transformed plant tissue cells or cultures which demonstrate cold tolerance are selected and plants which express antifreeze proteins and are cold tolerant are regenerated from these cultures. These plants may be reproduced, for example by cross pollination with a plant that is cold tolerant or a plant that is not cold tolerant. If the plants are self-pollinated, homozygous cold tolerant progeny may be identified from the seeds of these plants, for example by growing the seeds in a cold environment, using genetic markers or using an assay for cold tolerance or antifreeze protein activity. Seeds obtained from the mature plants resulting from these crossings may be planted, grown to sexual maturity and cross-pollinated or self-pollinated.
  • the nucleic acid molecule is also incorporated in some plant species by breeding methods such as back crossing to create plants homozygous for an AFP cold resistance nucleic acid molecule.
  • a plant line homozygous for the AFP nucleic acid molecule may be used as either a male or female parent in a cross with a plant line lacking the AFP tolerance nucleic acid molecule to produce a hybrid plant line which is uniformly heterozygous for the nucleic acid molecule. Crosses between plant lines homozygous for the AFP resistance nucleic acid molecule are used to generate hybrid seed homozygous for the resistance nucleic acid molecule.
  • the nucleic acid molecule of the invention may also be used as a marker in transformation experiments with plants.
  • a cold sensitive plant may be transformed with an antifreeze protein nucleic acid molecule and a nucleic acid molecule of interest which are linked. Plants transformed with the nucleic acid molecule of interest will grow in a cold environment in which the non-transformed plants are unable to grow.
  • nucleic acid molecules of invention may also be targeted for expression in only a certain part of the plant.
  • nucleic acid molecule expression may occur only in the fruit or harvested part of the plant to improve its quality during and after storage at low or freezing temperatures and to increase the shelf or storage life of the product.
  • the nucleic acid molecule of invention may also be expressed only in the temperature sensitive part of the plant such as flowers that bloom in spring when frost may occur or rootstocks that are sensitive to freezing in overwintering plants.
  • the nucleic acid molecules of invention may also be expressed at lower levels in plants already endowed with the nucleic acid molecules by using antisense technology or cosuppression to reduce expression of wild-type and introduced nucleic acid molecules when the strategy is to increase sensitivity of plants such as weedy species to freezing or low temperature diseases to decrease survival.
  • the present invention includes not only the chitinase-like AFP encoded by sequences presented in Figures 21 and 22 and the proteins described in the Examples, but also "biologically functional equivalent peptides, polypeptides and proteins” that exhibit the same or similar antifreeze activity as AFPs described in this application.
  • the phrase “biologically functional equivalent peptides, polypeptides, and proteins” denotes peptides, polypeptides, and proteins that exhibit the same or similar AFP activity as one or more of the AFPs of the invention when assayed as described in this application (see Example 5 for antifreeze assay).
  • the same or similar AFP activity is meant the ability to perform the same or similar function as the AFPs of the invention.
  • peptides, polypeptides, and proteins can contain a region or moiety exhibiting sequence identity to a corresponding region or moiety of the AFPs described in the application, but this is not required as long as they exhibit the same or similar AFP activity.
  • Identity refers to the similarity of two polypeptide (or nucleotide sequences) that are aligned so that the highest order match is obtained. Identity is calculated according to methods known in the art, such as the Gap or
  • Sequence A a polypeptide (called “Sequence A”) has 90% identity to a portion of the polypeptide in Figures 21 or 22, then Sequence A will be identical to the referenced portion of the polypeptide in Figures 21 or 22, except that Sequence A may include up to 10 point mutations ,such as deletions or substitutions with other amino acids , per each 100 amino acids of the referenced portion of the polypeptide in Figures 21 or 22.
  • Peptides, polypeptides, and proteins biologically functional equivalent to the AFPs of the invention can occur in a variety of forms as described below.
  • AFPs described in the application are also useful as an antigen for the preparation of antibodies that can be used to purify or detect AFPs or other AFP-like proteins.
  • Monoclonal and polyclonal antibodies are prepared according to other techniques known in the art. For examples of methods of the preparation and uses of monoclonal antibodies, see U.S. Patent Nos. 5,688,681 , 5,688,657, 5,683,693, 5,667,781, 5,665,356, 5,591 ,628, 5,510,241 , 5,503,987, 5,501 ,988, 5,500,345 and 5,496,705. Examples of the preparation and uses of polyclonal antibodies are disclosed in U.S. Patent Nos.
  • Antibodies recognizing AFPs can be employed to screen organisms containing AFPs or AFP-like proteins. The antibodies are also valuable for immuno-purification of AFPs and AFP-like proteins from crude extracts.
  • Peptides, polypeptides, and proteins biologically functionally equivalent to AFP protein include amino acid sequences containing amino acid changes in an AFP sequence.
  • the biologically functional equivalent peptides, polypeptides, and proteins have at least about 40% sequence identity, preferably at least about 60%, at least about 80%, at least about 90% or at least about 95% sequence identity, to the naturally occurring polypeptide, or corresponding region. Most preferably, the biologically functional equivalent peptides, polypeptides, and proteins have at least 97%, 98% or 99% sequence identity to the naturally occurring protein, or corresponding region or moiety.
  • “Sequence identity” is determined by the Gap or BestFit. BestFit aligns the best segment of similarity between two sequences.
  • Alignments are made using the local homology algorithm of Smith and Waterman (1981) Adv. Appl. Math. 2:482-489.
  • the algorithm of Needleman and Wunsch (1970 J Mol. Biol. 48:443-453) is used in the Gap program.
  • the invention includes fragments of the polypeptides of the invention which retain the same or similar activity as the polypeptides of the invention.
  • Such peptides preferably consist of at least 5 amino acids. In preferred embodiments, they may consist of 6 to 10, 11 to 15, 16 to 25 or 26 to 50 amino acids of the polypeptides of the invention.
  • Fragments of the AFPs can be created by deleting one or more amino acids from the N-terminus, C-terminus or an internal region of the protein (or combinations of these), so long as such fragments retain the same or similar AFP enzymatic activity as the AFPs disclosed in the application. These fragments can be natural mutants of the AFPs, or can be produced by restriction nuclease treatment of an encoding nucleotide sequence. Fragments of the polypeptide may be used in an assay to identify compounds that bind the polypeptide. Methods known in the art may be used to identify agonists and antagonists of the fragments.
  • Fragments and variants of AFPs encompassed by the present invention should preferably have at least about 40% sequence identity, preferably at least about 60%, at least about 80%, at least about 90% or at least about 95% sequence identity, to the naturally occurring protein, or corresponding region or moiety. Most preferably, the fragments have at least 97%, 98% or 99% sequence identity to the naturally occurring polypeptide, or corresponding region. Sequence identiy is preferably measured with either the Gap or BestFit programs.
  • the invention also includes fragments of the polypeptides of the invention which do not retain the same or similar activity as the polypeptides but which can be used as a research tool to characterize the polypeptides of the invention.
  • Variants of the AFPs of the invention may be created by laboratory techniques such as mutagenesis (as described in Example 32) or splicing. Variants can also be naturally occurring mutants of the AFPs disclosed in the application. Variants of the proteins of the invention may be made, for example, with protein engineering techniques such as site-directed mutagenesis which are well known in the art for substitution of amino acids. A combination of techniques known in the art may be used to substitute, delete or add amino acids. For example, a hydrophobic residue such as methionine can be substituted for another hydrophobic residue such as alanine. An alanine residue may be substituted with a more hydrophobic residue such as leucine, valine or isoleucine.
  • An aromatic residue such as phenylalanine may be substituted for tyrosine.
  • An acidic, negatively charged amino acid such as aspartic acid may be substituted for glutamic acid.
  • a positively charged amino acid such as lysine may be substituted for another positively charged amino acid such as arginine.
  • Modifications of the proteins of the invention may also be made by treating a polypeptide of the invention with an agent that chemically alters a side group, for example, by converting a hydrogen group to another group such as a hydroxy or amino group.
  • Peptides having one or more D-amino acids are contemplated within the invention.
  • peptides where one or more amino acids are acetylated at the N-terminus.
  • peptide mimetics i.e. a modified peptide or polypeptide or protein
  • peptide mimetics i.e. a modified peptide or polypeptide or protein
  • the invention also includes hybrid genes and peptides, for example where a nucleotide sequence from the gene of the invention is combined with another nucleotide sequence to produce a fusion peptide.
  • a domain from an AFP nucleic acid molecule or other molecule of interest may be ligated to an AFP nucleic acid molecule encoding an AFP described in this application.
  • Fusion genes and peptides can also be chemically synthesized or produced using other known techniques.
  • the variants preferably retain the same or similar AFP activity as the naturally occurring AFPs of the invention.
  • the AFP activity of such variants can be assayed by techniques described in this application.
  • Variants produced by combinations of the techniques described above but which retain the same or similar AFP activity as the naturally occurring AFPs of the invention, are also included in the invention (for example, combinations of amino acid additions, deletions, and substitutions).
  • the invention also includes nucleotide sequences that are biologically functional equivalent to the sequences in Figures 21 or 22 or other sequences of the invention.
  • Biologically functional equivalent nucleotide sequences are DNA and RNA (such as genomic DNA, cDNA, synthetic DNA, and mRNA nucleotide sequences), that encode peptides, polypeptides, and proteins having the same or similar AFP activity as the AFPs shown in Figures 21 or 22 or disclosed in the application.
  • Biologically functional equivalent nucleotide sequences can encode peptides, polypeptides, and proteins that contain a region having sequence identity to a region of an AFP in this application.
  • the invention includes biologically functional equivalent nucleotide sequences that encode conservative amino acid changes within an AFP amino acid sequence and produce silent amino acid changes in the AFP sequences of the invention.
  • nucleotide sequences that are biologically functional equivalent to the sequences in Figures 21 or 22.
  • Biologically functional equivalent nucleotide sequences are DNA and RNA (such as genomic DNA, cDNA, synthetic DNA, and mRNA nucleotide sequences) that encode peptides. polypeptides, and proteins having non-conservative amino acid substitutions, additions, or deletions but which also retain the same or similar AFP activity as the AFPs shown in Figures 21 or 22 or disclosed in the application.
  • the DNA or RNA can encode fragments or variants of the AFPs of the invention.
  • fragments and variants are identified by assays as described above. These biologically functional equivalent nucleotide sequences. Fragments and variants of AFPs encompassed by the present invention should preferably have at least about 40% sequence identity or preferably at least about 60%, at least about 80%, at least about 90% or at least about 95% sequence identity to the naturally occurring polypeptide, or corresponding region or moiety. Most preferably, the fragments have at least 97%, 98% or 99% sequence identity to the naturally occurring polypeptide, or corresponding region. Sequence identiy is preferably measured with either the Gap or BestFit programs.
  • Nucleic acids biologically functionally equivalent to the AFPs in Figures 21 or 22 include:
  • DNAs originating from winter rye, and other antifreeze proteins may have its length altered by natural or artificial mutations such as partial nucleotide insertion or deletion, so that when the entire length of the coding sequence within Figure 21 (b), is taken as 100%, the biologically functional equivalent nucleotide sequence has an approximate length of about 60-120% thereof, preferably about 80-110% thereof; or (2) nucleotide sequences containing partial (usually 80% or less, preferably 60% or less, more preferably 40% or less of the entire length) natural or artificial mutations so that such sequences code for different amino acids, but wherein the resulting protein retains the same or similar AFP enzymatic activity as that of a naturally occurring antifreeze protein.
  • natural or artificial mutations such as partial nucleotide insertion or deletion
  • the mutated DNAs created in this manner should preferably encode a protein having at least about 40%, preferably at least about 60%, at least about 80, and more preferably at least about 90% or 95%, and most preferably 97%, 98% or 99% sequence identity to the amino acid sequence of the AFPs in Figures 21 or 22. Sequence identity can be assessed by the Gap or BestFit programs. C) Genetically Degenerate Nucleotide Sequences
  • nucleic acid sequence in Figures 21 or 22 and described in the application are not the only sequences which may be used to code for a peptide having antifreeze, glucanase, chitinase or thaumatin activity.
  • This invention includes nucleic acid sequences that have the same essential genetic information as the nucleic acid molecules described in the Figures 21 or 22.
  • Nucleic acid molecules (including RNA) having one or more nucleic acid changes compared to the sequences described in this application and which result in production of a polypeptide shown in Figure 21 or 22 are within the scope of the invention. Genetically degenerate forms of any of the other nucleic acid sequences discussed in this application are also within the invention.
  • nucleic acid molecules that have one or more nucleic acid changes that replace one or more of the amino acids shown in Figures 21 or 22 with a chemically similar amino acid.
  • nucleotide sequences encoding AFPs are shown in Figures 21 or 22 or easily determined by using the methods described in this application.
  • Other biologically functional equivalent forms of AFP-encoding nucleic acids can be easily isolated using conventional DNA-DNA or DNA-RNA hybridization techniques.
  • the present invention also includes nucleotide sequences that hybridize to one or more of the sequences in Figures 21 or 22 and their complementary sequences, and that encode expression for peptides, polypeptides, and proteins exhibiting the same or similar activity as that of the AFPs produced by the DNA in Figures 21 or 22 or its variants.
  • nucleotide sequences preferably hybridize to one or more of the sequences in Figures 21 or 22 under moderate to high stringency conditions (see Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.). Preferable conditions and are described Example 25.
  • the present invention also encompasses nucleotide sequences that hybridize to genomic DNA, cDNA, or synthetic DNA molecules that encode the amino acid sequence of the AFPs of the invention, or genetically degenerate forms thereof due to the degeneracy of the genetic code, under salt and temperature conditions equivalent to those described in this application, and that code on expression for a peptide, polypeptide, or protein that has the same or similar antifreeze enzymatic activity as that of the antifreeze proteins of the invention.
  • nucleotide sequences described above are considered to possess a biological function substantially equivalent to that of the AFP genes of the present invention if inhibition of recrystallization or modification of ice crystal growth can still be observed in a solution when the encoded polypeptide is present at a concentration of 10 g /L or less, preferably 1 g/L or less , and more preferably 100 mg/L or less.
  • Example 38 Probes The invention also includes oligonucleotide probes made from the cloned
  • APF nucleic acid molecules described in Example 25 or other nucleic acid molecules of the invention may be 15 to 30 nucleotides in length and are preferably at least 30 or more nucleotides. Preferred probes are described in Example 25.
  • the probes are useful to identify nucleic acids encoding antifreeze peptides, polypeptides and proteins from plants other than those described in the application, as well as peptides, polypeptides, and proteins biologically functionally equivalent to the AFPs described in this application.
  • the oligonucleotide probes are capable of hybridizing to one or more of the sequences shown in Figures 21 or 22 or the other sequences of the invention under stringent hybridization conditions.
  • a nucleic acid molecule encoding a peptide of the invention may be isolated from other organisms by screening a library under moderate to high stringency hybridisation conditions with a labeled probe. The activity of the peptide, polypeptide, or protein encoded by the nucleic acid molecule is assessed by cloning and expression of the DNA as described in Example 25. After the expression product is isolated, the peptide, polypeptide or protein is assayed for antifreeze activity as described in this application. The expression product may also be assayed for glucanase, chitinase or thaumatin activity.
  • Biologically functional equivalent AFP genes from other plants, or equivalent AFP-encoding cDNAs or synthetic DNAs can also be isolated by amplification using Polymerase Chain Reaction (PCR) methods.
  • Oligonucleotide primers, including degenerate primers, based on the amino acid sequence of the sequences in Figures 21 or 22 can be prepared and used in conjunction with PCR technology employing reverse transcriptase (E. S. Kawasaki (1990), In Innis et al., Eds., PCR Protocols, Academic Press, San Diego, Chapter 3, p. 21) to amplify biologically functional equivalent DNAs from genomic or cDNA libraries of other organisms.
  • reverse transcriptase E. S. Kawasaki (1990), In Innis et al., Eds., PCR Protocols, Academic Press, San Diego, Chapter 3, p. 21
  • the oligonucleotides can be used as probes to screen cDNA libraries.
  • the expression vectors of Example 25 provide high levels of protein expression. Plants and cell cultures transformed with the nucleic acid molecules of the invention are useful as research tools. Plants and cell cultures are used in research according to numerous techniques known in the art.
  • a cell line (either an immortalized cell culture or a primary cell culture) may be transformed with a vector containing an AFP nucleic acid molecule (or variants) to measure levels of expression of the nucleic acid molecule and the activity of the nucleic acid molecule.
  • a polypeptide of the invention may be used in an assay to identify compounds that bind the polypeptide. Methods known in the art may be used to identify agonists and antagonists of the polypeptides. One may obtain plants that do not express AFPs and use them in experiments to assess AFP gene expression.
  • Experimental groups of plants may be transformed with vectors containing different types of AFP genes (or genes similar to AFPs or fragments of AFP nucleic acid molecules) to assess the levels of protein produced, its functionality and the phenotype of the plants produced.
  • the polypeptides are also useful for in vitro analysis of AFP activity.
  • the protein produced can be used for microscopy or X-ray crystallography studies.
  • Other expression systems can also be utilized to overexpress the AFPs in recombinant systems.
  • DNA and RNA molecules encoding glucanase-like and thaumatin-like AFPs from winter rye are cloned using the inventive method described in Example 25.
  • a cDNA library produced from mRNA isolated from healthy tissues of cold-acclimated winter rye is screened as described in Example 25 using heterologous probes obtained from a monocot, preferably a member of the Poaceae family, which encodes a glucanase or a thaumatin-like protein and which has been shown by Northern blotting to hybridize with transcripts of the cold-induced rye AFPs under moderate stringency as described in Example 25.1.
  • the positive clones identified by hybridization with these probes are characterized and sequenced as described in Example 25.
  • the cDNAs are expressed by transformation of plants as described in Examples 27 and 39 or in other expression systems as described in Examples 28, 29, 30, 31 and 34.
  • Biologically functionally equivalent peptides, polypeptides and proteins, variants of these AFPs, and biologically functionally equivalent nucleic acids of glucanase-like and thaumatin-like AFPs and their nucleic acid sequences as described in Examples 35, 36 and 37 are also included in this invention.
  • This invention also includes probes for nucleic acids encoding glucanase-like and thaumatin-like AFPs as described in Example 38.
  • Example 41 Production of AFPs for Use as Additives in Foods or Storage of Biological Materials
  • Peptides, polypeptides or proteins encoding AFPs or biologically functionally equivalent AFPs synthesized in a prokaryotic or eukaryotic expression system may be produced as a crude extract, a partially purified extract or a purified peptide, polypeptide or protein for use in a food product or biological material.
  • inventive DNA in Fig. 21 or 22 may be expressed in a plant and then a total soluble extract as described in Examples 18 and 24 or an extracellular extract as described in Examples 1 , 15,19 and 20 may be obtained from the plant and used in a food product or biological material.
  • the peptide, polypeptide or protein may be purified by nickel ch ⁇ lation, by colloidal chitin affinity chromatography, by immunoaffinity chromatography or by any standard liquid chromatographic technique. If the peptide, polypeptide or protein produced in a prokaryotic or eukaryotic cell line has been secreted into the growth medium or retained internally within the cells, then a total soluble extract, partially purified extract or purified peptide, polypeptide or protein is prepared as an additive for a food product or biological material.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

Le seigle d'hiver, après induction à froid ou acclimatation, produit une famille de protéines antigel qui sont similaires aux protéines apparentées aux pathogènes. On procède au clonage de deux de ces protéines, qui sont toutes les deux des protéines de type chitinase, en utilisant des techniques de biologie moléculaire et on les exprime dans des systèmes de bactéries et de levures (Pichia) et dans Arabidopsis thaliana. Les protéines ainsi recombinées ont produit à la fois une activité de chitinase et une activité antigel. Cette invention concerne l'ADN et les séquences de ces protéines antigel de type chitinase, les modification de ces séquences, l'expression de ces protéines et leur application dans l'agriculture, dans l'industrie alimentaire et dans le domaine médical.
EP98937376A 1997-07-31 1998-07-31 Proteines antigel, adn et systemes d'expression Withdrawn EP1002101A2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90387297A 1997-07-31 1997-07-31
US903872 1997-07-31
PCT/CA1998/000745 WO1999006565A2 (fr) 1997-07-31 1998-07-31 Proteines antigel, adn et systemes d'expression

Publications (1)

Publication Number Publication Date
EP1002101A2 true EP1002101A2 (fr) 2000-05-24

Family

ID=25418191

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98937376A Withdrawn EP1002101A2 (fr) 1997-07-31 1998-07-31 Proteines antigel, adn et systemes d'expression

Country Status (5)

Country Link
EP (1) EP1002101A2 (fr)
CN (1) CN1273604A (fr)
AU (1) AU8620698A (fr)
CA (1) CA2299620A1 (fr)
WO (1) WO1999006565A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000049044A1 (fr) * 1999-02-19 2000-08-24 Astrazeneca Ab Expression de polypeptides helicobacter dans pichia pastoris
JP3234897B2 (ja) * 1999-03-25 2001-12-04 農林水産省北海道農業試験場長 低温発現型キチナーゼ遺伝子およびその単離方法
EP1181865A1 (fr) * 2000-08-23 2002-02-27 Universite Catholique De Louvain Solutions cryoprotectrices
WO2003055320A1 (fr) * 2002-01-04 2003-07-10 Unilever Nv Proteines antigel dans des legumes
US7132263B2 (en) 2002-09-09 2006-11-07 Agrigenesis Biosciences Limited Antifreeze proteins isolated from forage grasses and methods for their use
US7968767B2 (en) 2002-09-09 2011-06-28 Jeroen Demmer Antifreeze proteins isolated from forage grasses and methods for their use
KR100543063B1 (ko) * 2004-03-16 2006-01-20 (주)넥스젠 재조합 단백질의 제조 및 분리 방법
ES2334741B1 (es) * 2008-06-26 2011-02-17 Consejo Superior De Investigaciones Cientificas (Csic) Proteina crioprotectora con actividad quitinasa a bajas temperaturas,procedimiento para su obtencion y sus aplicaciones.
ES2334743B1 (es) * 2008-06-27 2011-02-17 Consejo Superior De Investigaciones Cientificas (Csic) Proteina crioprotectora con actividad 1-3 b - glucanasa a bajas temperaturas, procedimiento para su obtencion y sus aplicaciones.
CN104975034B (zh) * 2015-06-25 2018-11-27 吉林省农业科学院 羊草几丁质酶LcChi2基因在提高植物耐冷性方面的应用
BR112018000296A2 (pt) * 2015-07-07 2018-09-04 Seqirus UK Limited ensaios de potência de influenza
CN111471082A (zh) * 2019-01-24 2020-07-31 华东师范大学 一种萝卜苗质外体抗冻蛋白的提取方法
KR20240046159A (ko) * 2021-06-15 2024-04-08 글로바켐 엔브이 키틴분해 효소-기반 식물 보호제
CN117164674B (zh) * 2023-10-24 2024-02-02 上海水大技术转移有限公司 一种抗冻蛋白及其基因、酵母工程菌和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554521A (en) * 1984-03-26 1996-09-10 Dna Plant Technology Corporation Chitinase-producing plants
ES2223041T3 (es) * 1991-06-13 2005-02-16 Microstar Biotech Inc. Tolerancias al frio en plantas.
US5627051A (en) * 1995-06-07 1997-05-06 University Of Notre Dame Du Lac Nucleic acid sequences encoding dendroides antifreeze proteins
SK9099A3 (en) * 1996-07-26 1999-06-11 Unilever Nv Frozen confectionery products

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9906565A2 *

Also Published As

Publication number Publication date
WO1999006565A3 (fr) 1999-06-03
CA2299620A1 (fr) 1999-02-11
CN1273604A (zh) 2000-11-15
AU8620698A (en) 1999-02-22
WO1999006565A2 (fr) 1999-02-11

Similar Documents

Publication Publication Date Title
Mitsuhara et al. Induced expression of sarcotoxin IA enhanced host resistance against both bacterial and fungal pathogens in transgenic tobacco
Ohshimax et al. Enhanced resistance to bacterial diseases of transgenic tobacco plants overexpressing sarcotoxin IA, a bactericidal peptide of insect
EP0589928B1 (fr) Resistance des vegetaux au froid
Garcia‐Casado et al. Characterization of an apoplastic basic thaumatin‐like protein from recalcitrant chestnut seeds
Kenward et al. Type II fish antifreeze protein accumulation in transgenic tobacco does not confer frost resistance
Neuhaus et al. The function of vacuolar β-1, 3-glucanase investigated by antisense transformation. Susceptibility of transgenic Nicotiana sylvestris plants to Cercospora nicotianae infection
WO1999006565A2 (fr) Proteines antigel, adn et systemes d'expression
Zhang et al. An apoplastic chitinase CpCHT1 isolated from the corolla of wintersweet exhibits both antifreeze and antifungal activities
US5993808A (en) Chitinase, DNA coding therefor and plants containing same
Ishige et al. Identification of a basic glycoprotein induced by ethylene in primary leaves of azuki bean as a cationic peroxidase
US5852172A (en) Cold tolerances in plants
OH et al. A plant EPF‐type zinc‐finger protein, CaPIF1, involved in defence against pathogens
WO1995005467A9 (fr) Chitinase, adn codant pour cette derniere et plantes contenant cet adn
AU672636B2 (en) Antifungal chitin binding proteins and DNA coding therefor
Pautot et al. The induction of tomato leucine aminopeptidase genes (LapA) after Pseudomonas syringae pv. tomato infection is primarily a wound response triggered by coronatine
Newton et al. An osmotin-like cryoprotective protein from the bittersweet nightshade Solanum dulcamara
JPH07502976A (ja) 殺生物性蛋白質
US20060117411A1 (en) Enhancing plant pathogen resistance via increasing BiP levels
JP2001519671A (ja) 酸化ストレス耐性遺伝子
Honjoh et al. Improvement of freezing tolerance in transgenic tobacco leaves by expressing the hiC6 gene
KR20040101889A (ko) 식충성 식물 유래의 키티나제, 이를 암호화하는폴리뉴클레오타이드 서열 및 이의 분리방법 및 사용방법
Fujikawa et al. Functional role of winter-accumulating proteins from mulberry tree in adaptation to winter-induced stresses
US6291647B1 (en) Antifungal proteins, DNA coding therefor, and hosts incorporating same
US6495737B1 (en) Methods and compositions for improving salicylic acid-independent systemic acquired disease resistance in plants
De los Reyes Cold acclimation and chitinase gene expression in bermudagrass

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000229

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: GRIFFITH, MARILYN

Inventor name: MOFFATT, BARBARA

Inventor name: XIONG, FEI

Inventor name: HEW, CHOY

17Q First examination report despatched

Effective date: 20030709

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040203